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Abstract:
It has long been accepted that a protein’s fold informs its function, but for the vital proteins
that don’t adopt one specified fold, this is uninformative. Intrinsically disordered proteins have
non-folded regions (IDRs) in their native functional state, which make up 30% of eukaryotic
proteins, perform vital cellular processes and contribute to a multitude of disease states. Yet,
IDR’s function, interactions and dynamics remain unknown due to their unstable, dynamic, lengthy
and solvent-exposed nature. This, along with their tendency for insolubility and aggregation
provide formidable challenges to not only their analysis, but their purification, requiring lengthy
optimizations. NMR is valuable for IDR analysis, but limited to shorter sequences, due to severe
spectral overlap characteristic of large IDRs. Segmental labeling of IDR containing proteins with
NMR active isotopes reduces spectral overlap while maintaining the protein’s structural context.
Segmental labeling was achieved with S. aureus sortase A via sortase-mediated ligations (SML),
stitching N- and C- termini of proteins together and providing independent labeling of each protein
half. This method was applied to large IDR-containing proteins; A. thaliana villin isoform 4 (V4)
and H. sapiens dematin isoform 2. These understudied cytoskeleton regulators are involved in a
multitude of essential cellular functions, whose analysis could have valuable implications in
agriculture (V4) and human health (dematin).

Segmentally labeled V4 samples allowed

assignment of V4’s C-terminal IDR segment and probing of its temperature sensitivity with
straightforward and expedient NMR experiments. Demonstrating this method’s compatibility with
large IDRs short lifespans. SML generated isotopically segmentally labeled dematin, further
proved the method’s value for IDR analysis. Segmentally labeled dematin would allow full length
dematin NMR spectra to be recorded with reduced spectral overlap. This provides a means to
characterize the non-covalent interface between the IDR and its phosphorylated C-terminal folded
domain that halts its F-actin bundling capabilities, which represents a relevant regulatory
mechanism for human health. This work demonstrates the versatility and adaptability of SML to
generate segmentally labeled IDR containing proteins and its benefits for IDR analysis. This may
make IDR analysis more achievable, providing valuable insights across disciplines from human
health to agriculture due to IDRs essential roles within eukaryotes.
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Section 1. Introduction
1.1 Significance of disordered proteins
Intrinsically disordered regions (IDRs) are non-folded regions present within a protein in
their native functional state.1,2 Sizable IDRs of greater than 50 residues are not rare; 30% of
eukaryotic proteins contain such regions.2,3 IDRs are multifunctional, performing crucial cellular
processes for organisms1–3 and are implicated in a multitude of disease states such as blood
diseases, and cancer.4 Many critical plant proteins also contain IDRs; IDRs have huge
agricultural applications and have the potential to help feed the world.5 Despite their relevance,
much remains unknown about this vital protein class and IDR’s functions, interactions, and
structural dynamics remain mysterious (Figure 1.1).

Figure 1.1 Displaying an anthropomorphic rendering of a mysterious intrinsically disordered
region attached to a cartoon rendering of dematin’s folded domain (PDB: 1QZP).
1.2 Challenges of IDR analysis
IDRs are still mystifying the scientific community due to the challenges of studying
them.1,2 IDRs are inherently unstable, degrading rapidly from various chemical mechanisms
and proteolysis.1 Crystallography and spectroscopy of IDRs are thwarted by their short
lifespans, which limit recording times.1–3 IDRs are highly dynamic which makes them
incompatible with crystallography.1,3 IDRs also tend to have long sequence lengths, causing
severe spectral overlap that hinders analysis by nuclear magnetic resonance spectroscopy
(NMR).6–10 IDRs are easy targets for post translational modifications (PTMs) due to their

solvent-exposed nature.1,11This results in results in IDRs with high heterogeneity of PTMs
challenging probing of specific modifications in vitro.1,11
Apart from the difficulties of analyzing IDRs, getting them pure for analysis is another
formidable challenge in itself. Current standard protein purification schemes are designed for
folded proteins whose structured nature behaves differently than that of proteins with IDRs.1,12
This is due to the propensity of IDRs to be insoluble, degrade and aggregate, which all
complicate their purification.12 Thus, getting soluble concentrated pure samples of IDRcontaining proteins can take significant optimization.

1.3 IDR methodologies needed
NMR is currently used in the field to study this vital protein class.6–8 NMR is compatible
with IDR’s highly dynamic nature and allows for analysis of their binding interfaces and
dynamics.8–10 Yet, NMR is limited to short IDRs (less than 100 residues) due to each residue
having similar chemical environments (i.e. solvent exposed) resulting in severe spectral
overlap.6–9 One way to reduce spectral overlap is with longer recording times, but this is often
beyond the short lifespan’s of many IDRs.7–10
Evidence that current tools in the field need improvement is apparent by the scarce
number of Biological Magnetic Resonance Bank (BMRB) entries for proteins with large IDRs.
Currently there are only 100 BMRB entries with IDRs greater than 100 residues in length, with a
publication rate of 4 BMRB entries added per year. 13 This is in contrast with the DisProt data
bank, a data bank that scientists update with verified IDRs, which currently contains about 1000
large IDR entries.14 IDRs are a vital class of proteins and thus knowledge of IDR’s could
improve therapeutics and have other valuable applications in areas such as agriculture.4,5,15,16

1.4 Vital protein family containing large IDRs
Specifically, we will be analyzing proteins from a family of cytoskeleton regulators.
Cytoskeleton regulating proteins are vital for organisms, regulating cell cycle, shape, mobility
and intercellular interactions.11,15–21 The protein class of interest here performs cytoskeleton
regulation through binding and or bundling of filamentous actin (F-Actin).15–18,20,21 Structurally
this protein class has characteristic folded C-terminal head piece domains (HP) and large Nterminal IDRs (Figure 1.2)..18 They are implicated in numerous disease states.4,16,22–24 Here we
analyze plant villin isoform 4 (V4) and human dematin isoform 2 (dematin) (Figure 1.3).
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Figure 1.2 A visual representation of vital cytoskeleton regulating protein family containing large
IDRs.
V4 is hard to study due to its extremely large IDR. Yet, it is crucial for development of
plant root hairs. Thus its analysis could provide valuable insight for agriculture and combating
world hunger (Figure 1.3).5,15,17 Dematin’s 315 residue IDR challenges its analysis, but performs
many vital cellular processes (Figure 1.3).18–21,25–29 Dematin regulates the cytoskeleton, RhoA,
calcium mobilization, platelet signaling, along with erythrocyte membrane stability and
function.20,21,26,27,29 Dematin is also implicated in a multitude of disease states such as, but not
limited to, blood diseases, prostate cancer, brain trauma and additionally malaria.21–24 Despite
its critical functions, dematin remains under characterized due to its large IDR hindering our
analysis of it. This is evident by there only being 60 total dematin publications currently, which is
scarce in comparison to gelsolin’s approximate 2,000 publications to date. 30 This discrepancy is
due to gelsolin having a dramatically smaller IDR than dematin and is thus easier to study. 18,19,31
Therefore, a more thorough characterization of dematin is relevant to fundamental biology and
could prove beneficial for human health (Figure 1.3).
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Figure 1.3 Visual representations of V4 and dematin, the two vital large IDR-containing proteins
of interest here.
Currently, we know that phosphorylation of dematin’s folded headpiece domain by
protein kinase A inhibits dematin’s ability to bundle F-actin, a critical cellular role .32,33 The 15NHSQC of wildtype (WT) dematin shows the presence of a folded domain and a disordered
region as expected (Figure 1.4a). 32,33 But, when serine 381 is mutated to glutamic acid
(mimicking HP phosphorylation) the 15N-HSQC lacks the expected HP signals (Figure 1.4a).
32,33

However, when 102 N-terminal residues of dematin’s IDR are deleted (truncated dematin)

the HP signals remain in the
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N-HSQC no matter its phosphorylation state (Figure 1.4a). 32,33

This therefore implicates dematin’s N-terminal IDR segment as potentially interfacing noncovalently with the HP domain (Figure 1.4b).32,33 Notably, this putative IDR-HP interface formed
upon phosphorylation is uncharacterized due to the spectral overlap characteristic of dematin’s
large IDR.32,33 Despite the challenges associated with large IDRs, understanding of their
properties remains crucial to human health; improving our understanding of their vital cellular
mechanisms has the potential to provide more effective therapeutics.

Figure 1.4 Dematin’s HP phosphorylation. (a) 15N-HSQC footprints of the phosphorylation
mimic (S 138 to E) and unphosphorylated versions of full length and truncated dematin at 500
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MHz and 20 °C. 32,33 (b) Diagram of phosphorylation regulation of dematin’s F-actin bundling
abilities and hypothesized mechanism to explain its regulation and 15N-HSQC footprint.
1.5 Methodologies for IDR analysis
A current method for IDR analysis that addresses spectral overlap like that seen for
dematin in Figure 1.4a is segmental labeling (SL). SL is the selective incorporation of labels
(NMR active isotopes) into a region of the protein allowing analysis of that protein portion while
it is still in its native context within the whole of the protein (Figure 1.5).34,35 Segmental labeling
with NMR active isotopes decreases spectral overlap by reducing signal count to only the region
of interest.34,35 Segmental labeling can be achieved via various methods, here we utilized
sortase mediated ligations (SML) 36–39 due to its high specificity and minimal substrate
engineering requirements (Figure 1.6).36,40–42

Figure 1.5 Visual representation of segmental labeling of a cytoskeleton regulating proteins.
SML utilizes the enzyme sortase, a cysteine transpeptidase protein found in Grampositive bacteria that covalently decorates the cell wall with secreted proteins.36,40 Sortase has
been employed for a variety of protein engineering applications including segmental labeling of
proteins for NMR and other spectroscopic studies.37–39 Here we employ heptamutant sortase A
(SrtA). This is an engineered variant derived from sortase A of Staphylococcus aureus that is
notable for high reaction rates and specificity for LPXTG.38,42 Sortase allows two halves of a
protein to be combined via a transpeptidation reaction (Figure 1.6).36,40 The N-terminal domain
of the protein needs to contain the LPXTG substrate for sortase’s active site cysteine to cleave
between the threonine and the glycine.36,40 This generates a thioester-linked acyl enzyme
intermediate that undergoes nucleophilic attack from a nucleophile with a N-terminal glycine.
36,40

This nucleophile is present on the C-terminal portion of the protein.36,37,40,42 Nucleophilic

attack kicks off sortase and ligates the two fragments via an amide bond. 36,37,40,42 Thus, SML is
a way to stitch the N- and C-termini of a protein together allowing for specific labeling of either
segment (Figure 1.6). 36,37,40,42 IDRs are potentially great SML substrates. 41 Sortase requires
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the LPXTG motif to be highly solvent exposed, which is typical of IDRs.1,3,37,38,42 SML provides a
means to segmentally label IDRs to reduce their spectral overlap and aid in their analysis.

Figure 1.6 Sortase mediated ligation (SML) scheme showing its ability to stitch N and C termini
of a protein together.
Here, we have developed and adapted SML to segmentally label V4 and dematin to
provide a novel method of analyzing these two vital large IDR-containing proteins. This method
provided segmentally labeled V4 constructs that gave simplified NMR spectra. This strategy also
allowed for segmental assignment of V4’s 35-residue C-terminal portion of the villin 4 IDR through
expedient and simple NMR experiments. This was accomplished via selective incorporation of
13

C and or 15N isotopes into the acidic, 35-residue C-terminal portion of V4’s IDR where their NMR

resonances were treated as a collective. The validity of V4 segmental assignment was confirmed
via residue-specific assignment with straightforward 3D NMR experiments. Segmentally labeled
V4 revealed that its IDR segment is non-uniformly impacted by changes in temperatures, a critical
environmental factor for agricultural biochemistry. Adaptability and compatibility of this
methodology for use on large IDR containing proteins was additionally proven with its success in
generating segmentally labeled dematin via SML. This method, along with optimized expression
and purification of dematin, opens the door to probing dematin’s structure and dynamics in both
its unphosphorylated and phosphomimetic forms via NMR with reduced spectral overlap.
Segmental labeling of dematin could allow characterization of the IDR-HP non-covalent interface
hypothesized to form upon phosphorylation or S381E mutation, explaining its inability to bundle
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F-actin in its phosphorylated and phosphomimetic state. NMR analysis with reduced spectral
overlap and short recording times (beneficial for short life span of instable IDRs) demonstrates
the practicality of SML-generated segmentally labeled IDR containing proteins. This methodology
has the potential to make large IDR analysis more achievable; expanding our knowledge of these
essential proteins that could aid in combating problems in a wide range of fields from human
health to agriculture.

Section 2. Materials and Methods

2.1 Reagents and chemicals
Triglycine peptide, GGG, was obtained from Chem-Impex (cat# 04555). Diglycine peptide, GG,
was from Sigma (#G1002). For isotopic labeling, ammonium chloride (15N, 99%, cat# NLM467) and D-glucose (U-13C6, 99%, cat# CLM-1396) were obtained from Cambridge Isotope
Laboratories. NMR recordings required deuterium oxide (D, 99.9%) from Cambridge Isotope
Laboratories (cat# DLM-4). In biological procedures and in reaction solvents the water was
purified via a Milli-Q Advantage A10 system (Millipore). All other reagents and chemicals were
acquired from commercial sources and used without further purification.

2.2 Protein sequences utilized
2.2.1 A. thaliana villin 4 constructs: See apendix section 1.1 for constructs’ amino acid
sequences.

Figure 2.1 WT A. thaliana villin 4 (V4)engineered for SML. WT A. thaliana villin 4 (V4) has
974 residues with two folded domains represented in yellow rectangles connected by a
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disordered linker (IDR) represented in teal. This thesis utilized residues 877 to 974 of V4’s Cterminal sequence (outlined with black dashed boxes). These residues were engineered to
undergo SML via a sortase site (LPETGG) shown in navy. Purification was achieved with an Nterminal affinity tag (FH8 tag or His6-tag) shown in grey that could be cleaved from the construct
with TEV protease (TEV proteases cleavage site shown in purple).
FH8-IDR-HP63 (full length fusion of villin 4 IDR (residues 877-911) and HP63, generated either
through expression of full length protein or via sortase-mediated ligation of FH8-IDR-G and G2HP63; all contain single G spacer between IDR and LPXTG motif)
IDR-HP63 (full length fusion of villin 4 IDR (residues 877-911) and HP63, generated through
sortase-mediated ligation of FH8-IDR-G and G2-HP63; all contain single G spacer between IDR
and LPXTG motif and had FH8 solubility domain cleaved from the IDR)
His6-IDR-HP63 (control sample lacking sortase LPXTG motif, TEV cleavage site and FH8
domain)
TEV-G2-HP63 (HP63 engineered with a His6-tag and a TEV cleavage site)
G2-HP63 (HP63 with a N-terminal diglycine generated via TEV protease cleavage of TEV-HP63)

FH8-IDR (villin 4 IDR (residues 877-911) engineered with a N-terminal FH8 tag and a Cterminal sortase motif and His6-tag, initiator methionine absent in purified protein)
FH8-IDR-G (villin 4 IDR (residues 877-911) engineered with a N-terminal FH8 tag separated
from a C-terminal sortase motif and His6-tag via a Gly spacer, initiator methionine absent in
purified protein)
FH8-IDR-G3 (villin 4 IDR (residues 877-911) engineered with a N-terminal FH8 tag separated
from a C-terminal sortase motif and His6-tag via a G3 spacer, initiator methionine absent in
purified protein)
FH8-IDR-(G4S)2 (villin 4 IDR (residues 877-911) engineered with a N-terminal FH8 tag
separated from a C-terminal sortase motif and His6-tag via a (G4S)2 spacer, initiator methionine
absent in purified protein)
FH8-EDEED(villin 4’s acidic IDR patch engineered with a N-terminal FH8 tag separated from a
C-terminal sortase motif and His6-tag, initiator methionine absent in purified protein)
FH8 (FH8 tag generated via TEV protease cleavage of FH8-IDR-G)
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2.2.2 Dematin constructs: See apendix section 1.2 for constructs’ amino acid sequences.

Figure 2.2 WT Dematin engineered for SML. (a) WT dematin’s sequence with its IDR
represented in teal and it folded domain represented in yellow. S* is the phosphorylation site of
interest. (b) Dematin had its LQSTE mutated to LPSTG for SML (shown in navy). Dematin’s
phosphorylated HP was mimicked with a S381E mutation forming the phosphomimetic dematin.
Purification was achieved with an N-terminal affinity tag (FH8 tag, His6-tag or dual strep tag)
shown in grey that could be cleaved from the construct with TEV protease (TEV protease
cleavage site shown in purple).
Dem (Full length dematin with WT HP engineered with a sortase LPSTG motif and a N-terminal
FH8 tag, initiator methionine absent in purified protein, generated either through expression of
full length protein or via sortase-mediated ligation of G-DHP and DemIDR)
DemP (Full length dematin with the phosphomimetic HP (S381E) engineered with a sortase
LPSTG motif and a N-terminal FH8 tag, initiator methionine absent in purified protein, generated
either through expression of full length protein or via sortase-mediated ligation of G-DPHP and
DemIDR)
DHP(Dematin’s WT HP separated from a N-terminal His6-tag via a TEV cleavage site)
G-DHP (Dematin’s WT HP with a N-terminal glycine generated via TEV protease cleavage of
DHP)
DPHP (Dematin’s phosphomimetic HP separated from a N-terminal His6-tag via a TEV cleavage
site)
G-DPHP (Dematin’s phosphomimetic HP with a N-terminal glycine, generated via TEV protease
cleavage of DPHP)
DemIDR (Dematin’s IDR with a N-terminal FH8 tag (cleavable via TEV) and a C-terminal His6tag cleavable via Sortase LPSTG motif, initiator methionine absent in purified protein)
DS (Full length dematin with WT HP engineered with a sortase LPSTG motif and a N-terminal
dual strep tag, generated either through expression of full length protein or via sortase-mediated
ligation of G-DHP and DISH)
DPS (Full length dematin with the phosphomimetic HP (S381E) engineered with a sortase
LPSTG motif and a N-terminal dual strep tag, generated either through expression of full length
protein or via sortase-mediated ligation of G-DPHP and DISH)
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DISH(Dematin’s IDR with a N-terminal dual strep tag (cleavable via TEV site) and a C-terminal
His6-tag (cleavable via Sortase: LPSTG motif))

2.2.3 Enzymes: See apendix Section 1.3 for Enzymes’ amino acid sequences.
SrtA7M (Hepta-Mutant Staphylococcus aureus Sortase A engineered with a His6-tag)
TEV (TEV protease engineered with a His6-tag)

2.3 Plasmid design
The gene encoding heptamutant sortase A (SrtA7M) was cloned into the pET-30b(+)
expression vector and acquired from the laboratory of Hidde Ploegh. All other expression
vectors were obtained commercially via gene synthesis with desired fusion tags (FH8, His 6, dual
strep tag, sortase recognition site, TEV cleavage site). All V4 FH8-IDR variants and V4 HP63
constructs were acquired from ATUM and cloned into the pD441-SR plasmid backbone. V4
His6-IDR-HP63, and all dematin constructs were obtained from GenScript and were cloned into
the pET-24a(+) plasmid backbone.

2.4 Plasmid transformation for all expression vectors: standard heat shock procedure
Expression vectors (~0.2 µg) were transformed via heat shocking chemically competent
BL21(DE3) E.coli cells for 45 seconds at 42 °C before placing them on ice for 2 minutes. The
cells were then spiked with 500 μL Luria broth (LB: 10 g/L tryptone, 5 g/L yeast extract, 10 g/L
NaCl, pH 7), and incubated at 37 °C and agitated at 210 rpm for 45 minutes. The cells were
then plated on kanamycin (10 μg/mL) containing LB agar plates and incubated upside down
overnight at 37 °C.

2.5 Protein expression
Isolated transformants were grown in LB (10 g/L tryptone, 5 g/L yeast extract, 10 g/L
NaCl, 10 mg/L kanamycin, pH 7) at 37 °C and agitated at 210 rpm. The cells were allowed to
reach an optical density of ~0.6 - 0.8* at 600 nm (V-1200 Spectrophotometer, VWR) before
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induction with IPTG (0.8 mM final concentration). After 5 hours the cells were harvested via
centrifugation (6118 x g, 10 min, 4 oC, Sorvall Lynx 4000 centrifuge, Thermo Scientific, rotor:
F12-6x500 LEX, PN 096-062375). Pellets were stored at -20 oC to -80 oC until cells were lysed.
For 13C and or 15N incorporation transformants were grown to an optical density of 0.40.5 at 600 nm (V-1200 Spectrophotometer, VWR) in LB broth (10 g/L tryptone, 5 g/L yeast
extract, 10 g/L NaCl, 10 mg/L kanamycin, pH 7) at 37 oC with 210 rpm agitation. The cells were
then pelleted via centrifugation (4,000 x g, 20 min, 4°C, Sorvall Lynx 4000 centrifuge, Thermo
Scientific). Cell pellets were resuspended in 500 mL salt wash** (Minimal media (M9) without
nutrient sources: 6 g/L Na2HPO4 , 3 g/L KH2PO4, 0.5 g/L NaCl, 200 g/L vitamin B1, 120 g/L
MgSO4, 28 g/L CaCl2, 10 mg/L kanamycin, pH 7). The resuspended cells were then pelleted as
previously described and the pellets were resuspended in 500 mL M9** with 15N and or
labeled nutrients (9 g/L
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13

C
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NH4Cl, 6 g/L C-D-Glucose, 6 g/L Na2HPO4 , 3 g/L KH2PO4, 0.5 g/L

NaCl, 200 g/L vitamin B1, 120 g/L MgSO4, 28 g/L CaCl2, 10 mg/L kanamycin, pH 7). The cells
were allowed to equilibrate at 37 °C for 1 hour with 210 rpm agitation before induction with 0.8
mM IPTG. After 4 hours of expression, the cells were harvested via centrifugation at (6118 x
g,10 min, 4 oC, Sorvall Lynx 4000 centrifuge, Thermo Scientific, rotor: F12-6x500 LEX, PN 096062375). Pellets were stored at -20 oC to -80 oC until lysed.
*All non-isotopically enriched villin 4 constructs were grown to an OD 600nm of 0.6-0.8. While all
non-isotopically enriched dematin constructs were grown to an OD of 0.8-0.9 prior to induction
with IPTG.
** 15N incorporation of dematin utilized 1 L of salt wash and 1 L M9 instead of the 500 mL of salt
wash and M9 used for V4 constructs.

2.6 Lysate preparation
V4 constructs (found in soluble lysate fraction)
Cell pellets were resuspended in 5 mL lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10
mM imidazole, pH 8) per 1 L media culture. Lysozyme at a final concentration of 50 μg/mL was
added to the cell suspension and incubated on ice for 30 minutes. The suspension was
sonicated (Branson sonifier) for three 30 sec intervals at 50% duty on ice. DNase I (0.1 units
/mL) was incubated with the lysed cells for 30 min at room temperature prior to pelleting the
insoluble cell debris via centrifugation (36,000 x g, 30 minutes, 4 oC, Sorvall Lynx 4000
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centrifuge, Thermo Scientific: rotor: F20-12x50 LEX, PN 096-124375). The supernatants were
then filtered (0.22 μm filter) prior to further purification.

Dematin Constructs (found in both the soluble and insoluble lysate fractions).
Cell pellets were resuspended in 5 mL solubilizing buffer per 1 L media culture. The
solubilizing buffer used for constructs with a strep tag (DS,DPS,DISH) was Buffer W with 6 M
urea (6 M urea, 100 mM Tris-HCl, 50 mM NaCl,1 mM EDTA, pH 8.0); the solubilizing buffer
used for all other dematin constructs was IMAC solubilizing buffer (6 M urea, 300 mM NaCl, 10
mM imidazole, 50 mM NaH2PO4 (for DHP, DPHP, DEM IDR) or 50 mM Tris (for DEM, DEMP)
pH 8.0). The cell suspension was sonicated (Branson sonifier) at 50% duty on ice for four 10
second intervals with 10 second cool down intervals between each sonication cycle. The lysed
cells were then stirred overnight (16 hours) at 4 oC. Lysed cells then underwent centrifugation
(36,000 x g, 1 h, 4 oC, Sorvall Lynx 4000 centrifuge, Thermo Scientific). The supernatants were
then filtered (0.22 μm filter) prior to further purification.

2.7 Protein purification
2.7.1 Immobilized metal affinity chromatography (IMAC)
Native IMAC: (V4 IDR variants and DemIDR, G-DHP,G-DHP, TEV and SrtA7M)
Samples (clarified lysates or impure protein samples) were agitated and incubated with a
column volume (CV) of IMAC affinity resin (CV = 5 mL for 6 L LB expression) for 1 hour at 4 oC .
The slurry was added to a fritted glass gravity flow column where the flowthrough (FT) was
collected and the resin was washed with 8 CV (for V4 constructs) or 15 CV (for dematin
constructs) of IMAC wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM Imidazole, pH 8). The
resin was then incubated for 30 minutes at 4 oC in 3 CV (V4) or 9 CV (dematin) of IMAC elution
buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM Imidazole, pH 8). All Villin constructs were
purified with Talon® metal affinity resin. All dematin constructs were purified with QIAGEN
nickel nitrilotriacetic acid (Ni-NTA) Superflow resin. DHP and DPHP were further purified with
Talon® metal affinity resin as needed. All buffers were chilled to 4 oC prior to their use. All
fractions were collected on ice.
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Denatured IMAC: (DemIDR, DISH)
Procedure for denatured IMAC was identical to native IMAC except that all buffers
contained urea. 6 M urea was used for DISH IMAC while 8 M urea was used for DemIDR IMAC.
Prior to SML, DISH was also buffer exchanged from 6 to 2 M urea via IMAC. In this protocol, the
resin bound DISH was washed with 8-15 CV IMAC Wash buffer with 2 M urea, and eluted in 9
CV of Elution IMAC buffer with 2 M urea.

Denatured to Native IMAC: (DHP and DPHP, DemIDR, DISH)
A procedure identical to native IMAC was followed except that the lysate or protein
sample contained urea (typically 6 M) and all other buffers contained no urea.

2.7.2 Hydrophobic Interaction Chromatography (HIC)
Native HIC (V4 IDR containing proteins, Dem and DemP, DemIDR)
Clarified lysates were spiked with CaCl2 to a final concentration of 5 mM CaCl2 and
incubated with a column volume (CV, CV = 8mL for 6 L LB expression) of HIC resin (Phenyl
SepharoseTM 6 Fast Flow high sub, GE Healthcare) for 1 hour at 4 oC . The slurry was added to
a fritted glass gravity flow column where the flowthrough (FT) was collected and the resin was
washed with 8 CV (for V4 constructs) or 15 CV (for dematin constructs) of HIC wash buffer (25
mM Tris, 75 mM NaCl, 2.5 mM CaCl2, pH 7.6). The resin was then incubated for 30 minutes at 4
o

C in 3 CV (V4) or 9 CV (dematin) of HIC elution buffer (50 mM Tris, 5 mM EDTA, 150 mM

NaCl, pH 7.6). All buffers were chilled to 4 oC prior to their use. All fractions were collected on
ice. For Dem and DemP HIC was performed in the presence of 2M urea.

2.7.3 Strep purification:
Native Strep purification (DS,DPS,DISH)
Clarified lysates were treated with necessary amounts of Biotin blocking solution (IBA
Life Sciences BioLock: (70 U / 1 mL BioLock), (1 U BioLock / 1 μg biotin)) to bind the free
endogenous biotin from the E.coli culture (expected amount was 1.75 μg biotin per L*OD of
E.coli culture. Lysates and Biolock were incubated for 20 minutes on ice prior to purification.
The amount of Strep-Tactin XT® (Strep-Tactin XT® 4flow High capacity resin IBA life sciences,
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binding capacity: 16 mg/mL) required for each purification was calculated from the lysate’s
absorbance at 280 nm. The needed CV of resin was then equilibrated with 2 CV of Buffer W
(100 mM Tris-HCl,150 mM NaCl, 1 mM EDTA, pH 8.0) within a fritted gravity flow column. The
Biolock treated clarified lysate was then added to the Strep-Tactin XT® column. The flowthrough
was collected and the resin was next washed with 15 CV of buffer W. The protein was then
eluted in 3 CV buffer BXT (100 mM Tris-HCl,150 mM NaCl, 1 mM EDTA, 100 mM biotin, pH
8.0). All buffers were chilled to 4 oC prior to their use. All fractions were collected on ice. For
future use, the resin was regenerated with 15 CV of 3 M MgCl2, followed by 8 CV of buffer W.
The regenerated resin was stored in buffer W at 4 oC.
For impure protein generated from IMAC, the material in IMAC elution buffer was
suitable for strep purification without the need for Biolock due to IMAC having already rid the
sample of endogenous biotin. Otherwise, all other steps for strep purification were identical to
that of strep purification of a protein from clarified lysate.

Denatured Strep purification (DISH)
Identical to native strep purification procedures except the lysate and all buffers
contained 6 M urea. (Resin can only tolerate 6 M urea for up to 30 minutes, then needs to be
regenerated immediately with 15 CV of 3 M MgCl2, followed by 8 CV of buffer W with no urea.

Denatured to Native or 2 M urea (DS: 0 M urea, DPS: 0 M urea, DISH: 2 M urea)
Identical to native strep purification procedure except the lysate or impure protein
samples contained 6 M urea. All other buffers contained no urea (DS, DPS, DISH) or 2 M urea
(for DISH prior to SML).
2.7.4 Size exclusion chromatography (SEC)

As needed, impure protein samples were purified via SEC on an ÄKTAprime plus FPLC
system (GE Healthcare) equipped with a HiPrep TM 16/60 SephacrylTM S-100 HR column (120
mL CV, GE Healthcare). Protein was eluted at 0.5-1.0 mL/min in 20 mM PIPES, 50 mM NaCl
buffer (pH 6.8). The buffer was chilled on ice for SEC of dematin and tag-cleaved V4 IDRcontaining proteins.
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2.8 Enzymology and segmental labeling
2.8.1 Enzymatic affinity tag removal: TEV cleavage reactions

Preparation of G2-HP63 from V4 TEV-G2-HP63
Full length TEV-G2-HP63 was expressed and purified as described above. The purified
construct was then reacted with TEV protease at a 100:1 molar ratio of substrate to protease in
PIPES buffer (20 mM PIPES, 50 mM NaCl, pH 6.8) with 0.5 mM EDTA and 1 mM DTT
overnight at 20 oC. This 1.5 mL reaction mixture was then incubated with 300 μL of Ni-NTA
slurry (QIAGEN) for 1 hour at 4 oC with gentle agitation. The mixture was then flowed through a
glass fritted gravity flow column and the eluent containing the cleaved G2-HP63 was collected.
The resin was then washed with 8 CV of PIPES buffer to recover any residual G2-HP63. The
identity and purity of G2-HP63 in the column fractions was assessed with 15% SDS-PAGE. The
same procedure was completed for the 15N-labeled version of G2-HP63 ((15N)G2-HP63).
Generating FH8 solubility tag free segmentally labeled (15N)IDR-(14N)HP63 from V4
(15N)FH8-(15N)IDR-(14N)HP63
The purified construct ((15N)FH8-(15N)IDR-(14N)HP63) was reacted with TEV protease at
a 50:1 molar ratio of substrate to protease in PIPES buffer (20 mM PIPES, 50 mM NaCl, pH 6.8)
with 0.5 mM EDTA and 1 mM DTT overnight at 4 oC. The reaction mixture was spiked to with
CaCl2 to a final concentration of 5 mM, and incubated for 1 hour at 4 oC with one CV of HIC
resin (Phenyl SepharoseTM 6 Fast Flow high sub, GE Healthcare) calculated from the resin’s
binding capacity and the moles of reactants present. The mixture was then flowed through a
glass fritted gravity flow column and the flowthrough was collected containing the cleaved
product. The resin was then washed with 8 CV PIPES buffer to wash remaining cleaved product
from the column. The identity and purity of the column fractions was assessed with 15% SDSPAGE. The HIC flowthrough and wash fractions were then pooled and incubated with one CV of
Ni-NTA slurry (QIAGEN) calculated from the resin’s binding capacity and moles of protease
present for 1 hour at 4 oC. The mixture was flowed through a glass fritted gravity flow column
and the flowthrough was collected containing the cleaved (15N)IDR-(14N)HP63. The resin was
then washed with 8 CV of PIPES buffer to wash remaining cleaved product from the resin.
(15N)IDR-(14N)HP63 was then buffer exchanged to PIPES buffer (20 mM PIPES, 50 mM NaCl,
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pH 6.8) via a desalting column (Bio-Rad Econo-Pac 10DG Desalting Columns #732201). The
purity and identity of (15N)IDR-(14N)HP63 were confirmed with 15% SDS-PAGE and LC-ESI-MS.
Generating (15N)FH8 solubility tag from uniformly labeled (15N)FH8-IDR-HP63
Purified uniformly labeled (15N)FH8-IDR-HP63 was reacted with TEV protease at a 50:1
molar ratio of substrate to protease in PIPES buffer (20 mM PIPES, 50 mM NaCl, pH 6.8) with
0.5 mM EDTA and 1 mM DTT overnight at 4 oC. This 1 mL reaction mixture was incubated for 1
hour at 4 oC with 300 μL of HIC resin (Phenyl SepharoseTM 6 Fast Flow high sub, GE
Healthcare) equilibrated with HIC binding buffer (50 mM Tris, 150 mM NaCl, 5 mM CaCl 2, pH
7.6). The mixture was then flowed through a glass fritted gravity flow column and the resin was
washed with 3 x 600 μL of HIC wash buffer (25 mM Tris, 75 mM NaCl, 2.5 mM CaCl2, pH 7.6) to
wash unwanted protease, uncleaved reactant and unwanted cleaved product from the (15N)FH8
bound to the resin. (15N)FH8 was eluted with 300 μL of HIC elution buffer (50 mM Tris, 5 mM
EDTA, 150 mM NaCl, pH 7.6) and its identity and purity was assessed with 15% SDS-PAGE.

Generating G-DHP from DHP
Full length DHP was expressed and purified as described above. The purified construct
was then reacted with TEV protease (TEV) at a 100:1 molar ratio of substrate to protease in
PIPES buffer (20 mM PIPES, 50 mM NaCl, pH 6.8) with 0.5 mM EDTA and 1 mM DTT
overnight at 20 oC (this reaction was done while dialyzing out of IMAC elution buffer into PIPES
buffer). The reaction mixture was then incubated for 1 hour at 4 oC with one CV of Ni-NTA slurry
(QIAGEN) calculated from the resin’s binding capacity and moles of protease used. The mixture
was flowed through a glass fritted gravity flow column and the flowthrough was collected
containing the cleaved product. The resin was then washed with 8 CV of PIPES buffer to wash
remaining cleaved product from the resin. The identity and purity of G-DHP was assessed with
15% SDS-PAGE and LC-ESI-MS, and pure fractions were pooled for further experimentation.
The same procedure was completed for the 15N-labeled version of G-DHP ((15N)G-DHP).

Generating G-DPHP from DPHP
G-DPHP was generated from DPHP via the same procedure used for generating G-DHP
from DHP as described above. The same procedure was completed for the 15N-labeled version
of G-DPHP ((15N)DPHP).
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2.8.2 Sortase mediated ligations (SML)
Model SML between V4 FH8-IDR variants and triglycine GGG: (FH8-IDR FH8-IDR-G, FH8IDR-G3, FH8-IDR-(G4S)2, FH8-EDEED)
Ligations were completed on 100 µL scale and all reaction stock solutions were
prepared in PIPES buffer (20 mM PIPES, 50 mM NaCl, pH 6.8). Pure FH8-IDR variants were
each reacted at a final concentration of 50 μM and combined with 10 mM GGG and 10 μM
SrtA7M (SrtA with seven point mutations increasing its catalytic activity) at room temperature.
The reaction was monitored at 30 minute time intervals by LC-ESI-MS. The ligation progress
was estimated from the mass spectra via comparing deconvoluted peak areas of the unmodified
FH8-IDR substrate and the corresponding ligation product. In addition to the expected peaks the
spectra consistently showed peaks with a mass increase of ~41 Da, consistent with the
formation of MeCN adducts arising from the LC-ESI-MS mobile phase. Adduct peak areas were
included in the total substrate and ligation product amounts estimated for the reaction
conversion.

Generating segmentally labeled FH8-IDR-HP63 from FH8-IDR-G and GG-HP63:
SML of 15N-labeled samples of FH8-IDR-G and GG-HP63 were reacted in 1 to 2 mL of
PIPES buffer (20 mM PIPES, 50 mM NaCl, pH 6.8) with final reagent concentrations of 100 µM
FH8-IDR-G, 50 µM GG-HP63, and 10 µM SrtA7M for 4 hours at room temperature. For isolation
of the segmentally labeled product, the reaction mixture was next incubated for 1 hour at 4 oC
with Ni-NTA slurry (QIAGEN, resin amount equaled half the initial reaction volume). The mixture
was flowed through a glass fritted gravity flow column and the flowthrough containing the
ligation product was collected. The resin was washed with 3 CVs of PIPES buffer and the flow
through and wash fractions were pooled and further purified via SEC. The identity and purity of
all ligation products were assessed via 15% SDS-PAGE and LC-ESI-MS. The same procedure
was used to generate segmentally labeled FH8-IDR-HP63 containing 13C and 15N within its IDR.
Generating Dem from SML of G-DHP with DemIDR:
Ligations were completed on a 100 µL scale with final reagent concentrations of 125 µM
G-DHP, 25 µM DemIDR and 5 µM SrtA7M in PIPES Buffer (20 mM PIPES, 50 mM NaCl, pH 6.8).
The reaction was incubated for 3-6 hours at 4 oC. This reaction can be conducted in up to 2 M
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urea. Isolation of the ligated product Dem was not achieved due to the FH8 solubility domain
affinity handle being nonfunctional.

Generating DemP from SML of G-DPHP with DemIDR:
Ligations between G-DPHP and DemIDR to generate DemP were conducted the same
way as described for G-DHP reacting with DemIDR. This reaction can be conducted in up to 2
M urea. Isolation of the ligated product DemP was not achieved due to the FH8 solubility
domain affinity handle being nonfunctional.

Generation of DS (unphosphorylated) or DSP (phosphomimetic) via SML of DISH with GDHP or G-DPHP:
The ligation was completed on a 600 µL scale with final reagent concentrations of 50 µM
of G-DHP or G-DPHP, 5 µM of SrtA7M both in PIPES Buffer (20 mM PIPES, 50 mM NaCl, pH
6.8) and 10 µM of DISH in IMAC elution buffer with 2 M urea ( 2M urea, 20 mM NaH2PO4, 300
mM NaCl, 250 mM Imidazole, pH 8). The reaction was incubated for 4 hours at 4 oC, after which
it was spiked with 6 M urea to halt the reaction and degradation of the product. Note: SrtA7M
remains active in up to 2M urea.
Generation of segmentally labeled phosphomimetic dematin, DPS:(14N)DISH-(15N)DPHP:
The ligation was completed on a 2 mL scale with final reagent concentrations of 50 µM
of G-DPHP, 5 µM of SrtA7M both in PIPES Buffer (20 mM PIPES, 50 mM NaCl, pH 6.8) and 10
µM of DISH in IMAC elution buffer with 2 M urea (2 M urea, 20 mM NaH2PO4, 300 mM NaCl,
250mM Imidazole, pH 8). The reaction incubated for 6 hours at 4 oC, after which it was spiked
with 6 M urea to halt the reaction and degradation of the product.
Isolation of the SML product ((14N)DISH-(15N)DPHP):
The reaction mixture was first treated with a CV of IMAC resin (QIAGEN) that was 25%
of the initial reaction volume for 1 hour at 4 oC with agitation and 20 mM imidazole present. The
mixture was then transferred to a glass fritted gravity flow column and the flowthrough was
collected containing the ligation product and unreacted HP. The resin was then washed with 8
CV of IMAC wash buffer with 6 M urea (50 mM NaH2PO4, 300 mM NaCl, 20 mM Imidazole, 6 M
urea, pH 8.0) to separate remaining product from unreacted DISH and SrtA7M that are resin
bound. The IMAC flowthrough and wash fractions were pooled and incubated with a CV of
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Strep-Tactin XT® resin that was 50% of the initial reaction volume. The mixture was transferred
to a glass fritted gravity flow column where the flowthrough was collected and the resin was
washed with 10 CV of buffer W (100 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, pH 8.0) to wash
remaining unreacted HP from the SML product bound to the resin. The SML product was then
eluted in 3 CV of buffer BXT (100 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA,100 mM biotin, pH
8.0). The eluted (14N)DISH-(15N)DPHP was buffer exchanged to PIPES buffer (20 mM PIPES,
50 mM NaCl, pH 6.8) via a desalting column (Bio-Rad Econo-Pac 10DG Desalting Columns
#732201). The identity and purity of eluted fractions were assessed with 15% SDS-PAGE and
LC-QTOF-MS, and pure fractions were pooled for further experimentation.

2.9 Protein visualization and quantification
Sodium Dodecyl sulfate polyacrylamide gels (15% SDS-PAGE):
Identity of protein samples and their purity were assessed with (15% SDS-PAGE).

UV-Vis:
Concentrations of protein samples were determined via their absorbance at 280 nm
(NanodropTM ND-1000 spectrophotometer, ThermoFisher) and their calculated extinction
coefficients (Expasy ProtParam) via the Beer-Lambert Law.

2.10 Mass spectroscopy

Liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS)
LC-ESI-MS was performed using an Advion expressionL CMS mass spectrometer and a
Dionex Ultimate 3000 HPLC system equipped with a Phenomenex AerisTM 3.6 μm WIDEPORE
C4 200 Å column (100 x 2.1 mm). Sample separation occurred prior to reaching the mass
spectrometer via an aqueous: 95% H2O, 5% MeCN, 0.1% formic acid and organic: MeCN, 0.1%
formic acid) mobile phase at 0.3 mL/min (method: 10% organic from 0.0-1.0 min, linear gradient
of 10-90% organic from 1.0-7.0 min, 90% organic from 7.0-9.0 min, linear gradient of 90-10%
organic from 9.0-9.1 min, re-equilibration at 10% organic from 9.1-12.0 min). Protein charge
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ladder deconvolution was done via Advion Data Express software or the maximum entropy
algorithm provided by Analyst 1.4.2 software.

Liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS)
LC-QTOF-MS characterization was achieved using an Agilent advanceBio 6545XT
LC/QTOF mass spectrometer and an Agilent 1290 Infinity II UHPLC system equipped with a
Phenomenex AerisTM 3.6 μm WIDEPORE C4 200 Å column (100 x 2.1 mm). Sample separation
occurred prior to reaching the mass spectrometer via an aqueous: 95% H 2O, 5% MeCN, 0.1%
formic acid and organic: MeCN, 0.1% formic acid) mobile phase at 0.3 mL/min (method: 10%
organic from 0.0-1.0 min, linear gradient of 10-90% organic from 1.0-7.0 min, 90% organic from
7.0-9.0 min, linear gradient of 90-10% organic from 9.0-9.1 min, re-equilibration at 10% organic
from 9.1-12.0 min). Protein charge ladder deconvolution was done using Agilent BioConfirm
software.
BMRB’s mass calculator was utilized to assess 15N incorporation for NMR samples via the
proteins’ chemical formulas.

2.11 Nuclear magnetic resonance (NMR) spectroscopy:
V4 NMR samples contained 0.02 to 0.3 mM of the desired protein in 500 μL of NMR
buffer (20 mM PIPES, pH 6.8, 50 mM NaCl, 0.5 mM EDTA, 0.02% NaN3, 10% 2H2O). NMR
samples of dematin’s HP (G-DPHP and G-DHP) and full length dematin containing a FH8
domain (Dem and DemP) contained 0.03 to 1.5 mM protein in 500 μL of NMR buffer (20 mM
PIPES, pH 6.8, 50 mM NaCl, 0.5 mM EDTA, 0.02% NaN3, 10% 2H2O) full length dual strep
tagged dematin NMR samples contained 0.075-0.081 mM protein in 500 μL in NMR buffer (50
mM PIPES, pH 6.8, 200 mM NaCl, 0.5 mM EDTA, 0.02% NaN3, 10% 2H2O); All dematin NMR
samples were exchanged to NMR buffer from IMAC or strep elution buffers via a desalting
column (Bio-Rad Econo-Pac 10DG Desalting Columns #732201). NMR PIPES buffer provides a
broad pH range and has stable pKa over varied temperatures.
The impact of 2H2O on pH was not corrected. The 1H resonance of H2O at 4.78 ppm
relative to DSS at 25 °C was internally referenced for all samples. All NMR spectra were
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collected on a Bruker Avance III HD NMR spectrometer operating at 11.7 Tesla ( 1H resonance
frequency of 500 MHz) equipped with a room temperature broadband ( 1H-X) SmartProbe
(Western Washington University, Bellingham, WA, USA).
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N-HSQC spectra were acquired via

uniform sampling recording with 2048 and 256, 512, 132, or 128 indirect points. 15N-HSQC
spectra of dematin were recorded at 20 °C. 15N-HSQC spectra of V4 were recorded at 15 °C, 25
°C and 45 °C. Resonance assignment of V4 required standard 3D heteronuclear data collection:
HNCACB, CBCA(CO)NH, HN(CA)CO, HNCO, H(CCO)NH, HBHA(CO)NH. Data was processed
with NMRPipe software (8.9 Rev 2016.307.12.43 32-bit). Spectra were analyzed and visualized
via NMRViewJ software (One Moon Scientific Inc.). Segmental NMR assignment utilized SML to
segmentally label V4’s IDR or V4’s HP with isotopes allowing conclusive identification and
analysis of V4’s IDR and HP signals.

Section 3. Results and Discussion
3.1 Methodology for Segmental Assignment of IDR containing proteins as seen with
Villin 4:
3.1.1 V4 construct design
Plant villin 4 (V4) constructs served as test candidates demonstrating the validity of
segmental labeling via sortase mediated ligations (SML), and supporting the use of the method
for analyzing large IDR-containing proteins. These constructs were also used to demonstrate that
SrtA7M was compatible with having its SML site (LPXTG) directly adjacent to a folded domain.
Segmental labeling of V4 constructs allowed investigations into its IDR while in the presence of
its native adjacent HP domain. Only the most C-terminal 35 residues of V4’s IDR were utilized in
our trials. Due to not including the expected 11 residue PEST motif predicted to reside directly Nterminal of the selected IDR fragment (Figure 3.1.1 PEST motif residue in bold black). PEST
motifs complicate in vitro protein preparation due to being sites of extreme proteolytic degradation.
V4’s entire sequence is shown in Figure 3.1.1 along with the fragment experimented with here,
boxed in dashed lines. Plant villin proteins contain extraordinarily large disordered regions
compared to vertebrate villins. The reason for this difference is still unknown due to the challenges
of studying large IDRs.
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Figure 3.1.1 Full length V4 sequence. The N-terminal folded core fragment (in yellow) and Cterminal folded headpiece domain (HP63) shown in yellow are joined by an IDR (positions 721 911) shown in teal. The linker has N-terminal basic (residues 721 to 865) and C-terminal acidic
(residues 877 to 911) regions. A predicted 11-residue PEST motif (residues 866 to 910) separates
the basic and acidic regions of the linker. The fragment experimented with here is outlined with
black dashed lines.
In an attempt to combat the challenges of working with IDR containing proteins, we
engineered V4 for segmental labeling via SML. We fused a LPETG sortase motif to the C-terminal
end of V4’s 35 residue IDR fragment and included an additional C-terminal glycine due to its
known benefits for SML reaction rates.43 We engineered the V4 IDR constructs to contain Nterminal FH8 solubility domains and C-terminal His6-tags for purification purposes as described
in the Materials and Methods. V4’s HP domain was engineered to be able to undergo TEV
cleavage to reveal an exposed N-terminal glycine to serve as the nucleophile in the SML reactions
with V4 IDR constructs (Figure 3.1.2).
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Figure 3.1.2 V4 construct design and SML scheme. V4 is shown with its IDR in teal and its
folded domains in yellow. (a) V4’s C terminal acidic IDR region shown in teal outlined with dashed
black lines was engineered to undergo SML with V4’s HP (yellow outlined with dashed black
lines), that upon SML forms V4’s acidic IDR region ligated to its HP via a LPETGG motif (V4 SML
construct). (b) Pymol representations of engineered V4 constructs undergoing SML to form the
ligation product (V4 SML construct).
3.1.2 V4 SML optimization for segmental labeling
To assess sortase’s recognition of the LPETG motif within the V4 IDR construct (FH8IDR), model SML was conducted using excess GGG peptide and SrtA7M to ligate the GGG to the
C-terminus of FH8-IDR, thus forming FH8-IDR-GGG. The formation of the expected ligated was
verified via LC-ESI-MS, but the reaction rates were modest and never reached completion within
the 4 hour incubation period (Figure 3.1.3).
When investigating the low SML efficiency seen for FH8-IDR, we found that the LPETG
motif was directly adjacent to an extremely acidic pentapeptide region on the C-terminal end of
the V4 IDR segment (E907DEED911). This could be hindering SrtA7M’s substrate binding causing
the low SML efficiency seen. We hypothesized that the highly negative residues directly adjacent
to the LPETG could hinder the L of the motif from fitting into the hydrophobic pocket of sortase’s
substrate binding site44,45 and thus cause the lower SML efficiency observed for FH8-IDR (Figure
3.1.3a).
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To test this hypothesis, variants of the V4 IDR construct were designed with various spacer
lengths between the IDR’s EDEED segment and its LPXTG motif (FH8-IDR-G, FH8-IDR-G3, FH8IDR-(G4S)2). Model SML reactions between each V4 IDR variant and excess GGG were assessed
for reaction progress via LC-ESI-MS at room temperature over a 4 hour period (Figure 3.1.3b).

Figure 3.1.3 Diagram illustrating model SML ligation. (a) Shows the reaction that gave low
SML ligation efficiency and highlights EDEED amino acids of the IDR that potential hinder SrtA7M.
(b) Model system for testing whether EDEED is the cause of poor SML efficiency.
SML ligation efficiency increased with increased spacer lengths between the IDR and its
LPETG motif. FH8-IDR-(G4S)2, the V4 IDR construct with the largest spacer length of (GGGGS)2,
had the highest rates of reaction reaching completion in under 30 minutes (Figure 3.1.4a). The
other two V4 IDR construct variants, FH8-IDR-G and FH8-IDR-G3, with spacer lengths of GGG or
G provided practical improvements in SML reaction efficiency that reached greater than 90%
completion after 4 hours (Figure 3.1.4a,b). Formation of the desired ligation products (FH8-IDRG3-GGG, FH8-IDR-(G4S)2-GGG, FH8-IDR-G-GGG) were verified via LC-ESI-MS. This experiment
supported our hypothesis that the EDEED region of the IDR being directly adjacent to the LPETG
motif was causing the low SML efficiency seen for FH8-IDR. To further support this claim, a model
substrate with an FH8 solubility tag fused to the N-terminal end of an EDEED pentapeptide that
had an adjacent C-terminal LPETG motif (FH8-EDEED) was reacted with excess GGG (Figure
3.1.4c). Low SML efficiency was also observed when reacting FH8-EDEED with excess GGG for
4 hours at room temperature (Figure 3.1.4c). This further supported the determination that
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EDEED was detrimental to SML efficiency, but could be improved with a minimal insertion of one
glycine between V4’s IDR EDEED sequence and the LPETG motif (Figure 3.1.4b). The V4 FH8IDR-G variant was utilized for all following V4 SML reactions to provide acceptable reaction rates
with minimal perturbation to V4’s native IDR sequence.

Figure 3.1.4 Model V4 IDR SML results. (a) SML reaction progress for various spacer lengths
(X) estimated using LC-ESI-MS over a 4 hour time period. (b) Shows the mass spectra at 240
min of the IDR construct (FH8-IDR-G) providing practical SML efficiency with minimal sequence
perturbation (X = G). Calculated MWs: unmodified substrate = 14062 Da, ligation product = 13296
Da, * = MeCN adducts from LC-ESI-MS mobile phase). (c) Representative ESI-MS spectrum for
ligation reaction between triglycine (GGG) and FH8-EDEED (calcd. MW unmodified FH8-EDEED
substrate = 11257 Da, calcd. MW ligation product = 10491 Da) at the 30 min reaction time point.
Calculated MW values are average molecular weight predicted using the BMRB Molecular Mass
Calculator. * = MeCN adducts from LC-ESI-MS mobile phase (calcd. mass for MeCN adduct =
+41 Da).
The C-terminal ligation partner for FH8-IDR-G was V4’s 63 residue HP domain that was
shown to adopt a stable native fold in vitro17. This was fused with a diglycine separated from a
His6-tag via a TEV protease cleavage site (His6-TEV-G2-HP63). This construct, upon TEV
cleavage, results in an exposed N-terminal diglycine (GG-HP63) that serves as the nucleophile
in SML reactions.
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3.1.3 SML generated segmentally labeled V4 samples
His6-TEV-G2-HP63, and thus G2-HP63 (upon TEV cleavage), could be expressed in
(unlabeled) and

15

N (labeled) forms. The combination of labeled 15N G2-HP63 and unlabeled

FH8-IDR-G via SML yielded a segmentally labeled product with

15

14

N

14

N

N selectively incorporated into

the HP63 portion of the ligated product. Its isolation from the SML reaction mixture was achieved
with IMAC, removing His6 tagged SrtA7M and unreacted IDR substrate, followed by SEC to remove
unreacted G2-HP63. This process provided pure segmentally labeled V4 (FH8-IDR-HP63). Its
identity and purity were confirmed by SDS-PAGE and LC-ESI-MS (Figure 3.1.5).

Figure 3.1.5 SML generated segmentally labeled V4. (14N)FH8-IDR-(15N)HP63. (a) SML
strategy for producing segmentally labeled V4 derivative containing a 14N FH8-IDR segment (35residue acidic fragment) attached to 15N labeled headpiece domain of villin 4. (b) ESI-MS
spectrum of purified FH8-IDR-HP63 with selective incorporation of 15N in the HP63 segment
(calculated MW assuming 100% 15N incorporation in HP63 = 20797 Da, * = MeCN adducts from
LC-ESI-MS mobile phase). (c) 15N-HSQC (500 MHz, 25 oC) of uniformly labeled FH8-IDR-HP63.
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(d) 15N-HSQC (500 MHz, 25 oC) of segmentally labeled FH8-IDR-HP63 in which
restricted to HP63.

15

N labeling is

FH8-IDR-G was also able to be produced in 14N (unlabeled) and 15N (labeled) forms. The
combination of 15N labeled FH8-IDR-G 14N unlabeled G2-HP63 using SML yielded a segmentally
labeled product with

15

N selectively incorporated into the FH8-IDR portion of the ligated product.

Its isolation from the SML reaction mixture was achieved with IMAC, removing His 6 tagged
SrtA7M and unreacted IDR substrate, followed by SEC to remove unreacted G2-HP63. This
process provided pure segmentally labeled V4 (FH8-IDR-HP63) with selective incorporation of
15

N in the FH8-IDR segment. Its identity and purity were confirmed by SDS-PAGE and LC-ESI-

MS (Figure 3.1.6).

Figure 3.1.6 SML generated segmentally labeled V4: (15N)FH8-IDR-(14N)HP63. a) SML
strategy for producing segmentally labeled V4 derivative containing a 15N FH8-IDR segment (35residue acidic fragment) attached to 14N labeled headpiece domain of villin 4. (b) ESI-MS
spectrum of purified FH8-IDR-HP63 with selective incorporation of 15N in the FH8-IDR segment
(calculated MW assuming 100% 15N incorporation in IDR = 20797 Da, * = MeCN adducts from
LC-ESI-MS mobile phase). (c) 15N-HSQC (500 MHz, 25 oC) of uniformly labeled FH8-IDR-HP63.
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(d) 15N-HSQC (500 MHz, 25 oC) of segmentally labeled FH8-IDR-HP63 in which
restricted to the FH8-IDR region.

15

N labeling is

3.1.4 NMR analysis and segmental assignment of segmentally labeled V4 constructs
The
identical

15

N segmentally labeled construct ( 14N)FH8-IDR-(15N)HP63 produced a nearly

15

N-HSQC signature to that seen for the isolated headpiece domain (G 2-HP63). The
15

identical signature of the headpiece domain was also observed in the uniformly

N-labeled

analog, (15N)FH8-IDR-(15N)HP63. However this analog had many resonances obscured due to
severe spectral overlap that is characteristic of its

15

N labeled IDR. As a control for the impact of

the LPXTG motif insertion on V4’s structure we also assessed the

15

N-HSQC of

15

N uniformly

labeled V4 construct containing V4’s 35-residue acidic IDR fused to its native 63 residue HP
domain without the presence of the LPXTG sortase motif, FH8 solubility domain and TEV
cleavage site (His6-IDR-HP63). Analysis of this material revealed that the headpiece signatures
of the segmentally labeled (14N)FH8-IDR-(15N)HP63 construct gave HP resonances consistent
with the native V4 control construct. Overall, this confirmed that the LPXTG sortase motif didn’t
disrupt the HP’s native fold (Figure 3.1.7a).
We then made a segmentally labeled V4 construct containing

13

C and

15

N labeled FH8

and IDR ligated to unlabeled ( 14N) HP63 domain ((13C/15N)FH8-IDR-(14N)HP63). Its

15

N-HSQC

spectra revealed the expected signatures of the FH8 domain, determined via comparison with the
15

N-HSQC of free cleaved FH8 solubility domain (Figure 3.1.7b). The corresponding FH8

solubility domain resonances in both free and segmentally labeled samples confirmed that the
domain acts and folds the same no matter the presence of the V4 IDR and HP63 (Figure 3.1.6c
and Figure 3.1.7b). This allowed the identification of resonances from the FH8 solubility domain
to be accounted for and excluded in the segmentally labeled V4 spectra.

Figure 3.1.7 15N-HSQC of His6-IDR-HP63 (uniform 15N labeling) and 15N-HSQC spectra of
isolated FH8 (uniform 15N labeling). (a)15N-HSQC of His6-IDR-HP63 (uniform 15N labeling).
Data recorded at 25 oC on a 500 MHz instrument. This sample represents the native sequence of
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A. thaliana villin 4 (residues 877-974), including the 35-residue IDR segment and C-terminal
headpiece domain without the sortase-mediated ligation motif (LPXTG), FH8 domain, or the TEV
cleavage site. The only non-native element of His6-IDR-HP63 is the N-terminal His6-tag. Based
on the sequence of His6-IDR-HP63, we expect to observe up to 101 resonances originating from
non-proline residues. A conservative analysis of the spectrum acquired gives 88 resonances of
variable intensity. We attribute this apparent shortage in part to the presence of the His 6-tag on
the protein N-terminus. Due to their identical chemical nature, these six contiguous residues
would likely have nearly overlapping or closely packed peaks. Additionally, there is a region of
poor spectral resolution at ~8.3 ppm (1H dimension) and ~122 ppm ( 15N dimension) where
significant spectral overlap may prevent identification of more individual peaks. Lastly,
resonances may be undetectable due to their respective residues experiencing intermediate timescale dynamics. (b) 15N-HSQC spectra of isolated FH8 (uniform 15N labeling) recorded at 25 oC
(500 MHz 1H frequency).
Based on the resonances of FH8 in isolation, we could then deduce that the remaining
resonances were part of V4’s IDR without performing residue-specific assignment for individual
resonances. Segmental labeling of V4 thus allowed for segmental assignment of its IDR. At 25
°C, segmental assignment of the IDR revealed 40 to 45 resonances with minor uncertainty from
the spectral overlap within 7.8 - 8.7 ppm, the region associated with IDRs’ chemical shift (Figure
3.1.8a). All the resonances assigned to V4’s IDR had 1H chemical shifts within this ppm range,
consistent with the resonances being from V4’s IDR (Figure 3.1.8a). Segmental assignment of
the IDR was expected to produce 40 resonances. We attributed 35 of the observed resonances
to be that of the acidic IDR fragment, 5 peaks were expected from the GLPET sortase motif and
1 signal from the G spacer between the IDR and the GLPET sortase motif. The overall agreement
between the number of resonances expected and the number of resonances identified via
segmental assignment was therefore very good.
To probe the accuracy of our segmental assignment of V4’s IDR we utilized standard
2D/3D heteronuclear NMR experiments (15N-HSQC, HNCACB, CBCA(CO)NH, HNCO,
HN(CA)CO). This allowed for residue-specific backbone resonance assignments of the FH8-IDR
portion of the segmentally labeled (13C/15N)FH8-IDR-(14N)HP63 sample. Overall, we were able to
unambiguously assign 97 out of the 115 non-proline residues (Figure 3.1.8a, BMRB entry:
50205). Of the 35 residue acidic region of V4’s IDR, 27 (77%) residues were assigned. The seven
out of eight unassigned residues occupy two segments in the sequence: positions 90 - 93 (three
Ser residues out of four in the segment) and 110-112 (all are Glu and Asp). Potentially, a
significant fraction of the unassigned resonances cluster within a massive overlap located near
(8.40 ppm (1H), 121.5 ppm (15N)). It is also possible that the unassigned segments display
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intermediate time scales of conformational motion and or exchange with the solvent and thus
were not detected on the spectra. However, segmental assignment did simplify resonance
assignments due to the HP being unlabeled. It also allowed for resonances to be unambiguously
assigned to the FH8 solubility domain (open red countours on Figure 3.1.8a).

Figure 3.1.8 15N-HSQC NMR spectra (25 oC) of segmentally labeled FH8-IDR-HP63 and IDRHP63. (a) Spectrum recorded at 500 MHz (1H frequency) with 256 indirect increments using a
FH8-IDR-HP63 sample with the FH8-IDR portion segmentally labeled with 13C/15N isotopes. All
observed resonances for the labeled FH8-IDR segment are represented by open red contours,
and signals that have been segmentally assigned to the IDR linker portion are overlaid with solid
red ovals. Residue-specific NMR assignments for 36 residues in the linker region (27 from the
villin 4 IDR and 9 residues from the flanking TEV and sortase ligation sites) and four FH8 domain
peaks are indicated with residue numbers. The numbers for the TEV site (7 residues) are shown
in grey, FH8 domain (4 residues) are shown in blue, and two residues corresponding to the SML
ligation (G114, L115) are shown in green. Seven segmentally assigned peaks for which no
residue specific assignments were obtained are marked with “+”. Residue numbers shown
correspond to the sequence of FH8-IDR-HP63. To relate the assigned IDR residues to the
corresponding positions in wild type villin 4, a value of 798 should be added. (b) Spectrum
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recorded at 500 MHz (1H frequency) with 196 indirect increments using an IDR-HP63 sample with
the IDR segmentally labeled with 15N isotopes. All observed resonances for the labeled IDR
segment are represented by solid red signals. Residue-specific NMR assignments for 25 residues
in the linker region were unambiguously transferred from panel (a) (out of 27 listed on panel (a)).
The resonances for the two remaining residues E79 and E80 (adjacent to G78 at the N-terminus
in the IDR-HP63 sample) are not found at the same locations as on panel (a) and are presumed
to correspond to the two peaks marked X and Z, which are unique to panel (b) and absent from
panel (a). The residue number for the TEV site (G78) is shown in grey, and two residues
corresponding to the SML ligation (G114, L115) are shown in green. Six peaks for which no
residue specific assignments were obtained are marked with “+”.
As a final assessment of segmental assignment we employed the same V4 control
construct previously described without the presence of the LPETG sortase motif, FH8 solubility
domain or TEV cleavage site (His6-IDR-HP63, Figure 3.1.7a). This control sample’s spectra
provided 26 signals that irrefutably correspond to V4’s IDR resonances identified via segmental
assignment of the segmentally labeled (13C/15N)FH8-IDR-(14N)HP63 sample (Figures 3.1.7a and
3.1.8a). Of the 26 corresponding signals found with the control sample, four had matches with
chemical shift differences of greater than 0.05 ppm (1H axis) and 0.2 ppm (15N axis). When
comparing this V4 control sample’s spectra to the residue-specific assignment of the segmenatlly
labeled V4 sample we find all 27 IDR identified residues have correspondants with the control V4
sample (Figures 3.1.7a and 3.1.8a). All these experiment suggest that the insertions of the
sortase motif and additional glycines between the IDR and HP have minimal perturbations to V4’s
IDR.
Before we could perfrom any investigations of V4 we needed to deduce if the N-terminal
FH8 domain impacts the spectral signatures of the IDR. This was accomplished by generating
segmentally labeled V4 samples, ( 15N)FH8-IDR-(14N)HP63, and (15N)IDR-(14N)HP63, where its Nterminal FH8 tag was cleaved with TEV protease, thus creating segmentally labeled V4 samples
with and without the N-terminal FH8 tag. Both (15N)FH8-IDR-(14N)HP63, and (15N)IDR-(14N)HP63
still contain the GLPETGG sortase ligation sites connecting the
headpiece (HP63) domain.
the

15

15

15

15

N-labeled IDR and unlabeled

14

N-HSQC spectrum of ( N)FH8-IDR-( N)HP63 was compared with

N-HSQC spectrum for (15N)IDR-14N-HP63 to assess the impact of the FH8 tag’s presence

(Figures 3.1.8a,b). With the exception of a few N-terminal residues, resonances for all the
assigned IDR residues were found at nearly identical positions for FH8-IDR-HP63 and its FH8free counterpart IDR-HP63 (changes <0.05 ppm for 1H and <0.2 ppm for

15

N values) (Figure

3.1.8b and Table 3.1.1).
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Only the two N-terminal IDR residues that were initially adjacent to the FH8/TEV portion
(E79, E80) demonstrated noticeable

15

N-HSQC resonance differences (peaks repositioning or

disappearing). The next two adjacent peaks from residues (K81, K82) moved, but remained
relatively consistent and identifiable. The comparison of the 15N-HSQC signatures of the FH8-free
variant (IDR-HP63, Figure 3.1.8b) and our native control, His6-IDR-HP63 (Figure 3.1.7a), also
provided evidence that the GLPETGG inserted for SML caused effectively no perturbation of the
native V4 IDR fragment (Table 3.1.1). Only the two residues, K81 and K82, were appreciably
effected, but it was expected by the fact that the two samples compared had chemical differences
at their N-termini: Gly78 for IDR-HP63 (the single remaining residue from the TEV cleavage site)
and His6-tag for His6-IDR-HP63.
Table 3.1.1 Summary of 15N-HSQC spectral changes attributed to the presence of the FH8 tag
and non-native residues (GLPETGG) inserted for sortase-mediated ligation.
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3.1.5 Segmentally labeled V4 IDR sample allows investigation of IDR’s temperature
sensitivity
Successful segmental labeling and assignment, along with the mutations made to V4
providing minimal IDR perturbations, allowed investigation of V4’s IDR at various temperatures.
Plants, including V4, are exposed to a range of temperatures from subzero to more than 40 oC in
nature. Therefore, being able to probe plant protein’s IDRs at a wide range of temperatures is
valuable to understanding potential temperature dependent property modulation relevant to plant
biochemical and physiological operations.
Tertiary structural changes are seen in V4’s HP between 10 to 40 oC17, leading to the
hypothesis that temperature sensitivity could also be seen in the 35 residue acidic region in our
V4 IDR constructs being directly adjacent to V4’s temperature sensitive HP domain. To test this,
15

N-HSQC spectra of (15N)IDR-(14N)HP63 at 15, 25 and 45 oC were collected (Figure 3.1.9).

Segmental assignment of the IDR residues at all temperatures were found in the expected ppm
range associated with disorder (Figure 3.1.9a,b). Resonances observed at 15 oC (39-42)
correspond well to the number of signals expected for the labeled segment of the IDR-HP63
sample, with 40 non-proline residues (Figure 3.1.8b). The spectrum recorded at 25 oC displayed
four fewer peaks than the spectrum obtained at 15 oC, possibly due to intermediate timescale of
conformational or chemical exchange processes (Figure 3.1.9a). Segmentally assigned IDR
resonances from the 15N-HSQC spectrum recorded at 45 oC revealed about 50% of these peaks
have highly similar positions and form similar multi-peak patterns to those observed at 15 oC and
25 oC (Figure 3.1.9). Remaining peaks in the 45 oC spectrum dramatically decreased in
intensities, suggesting the acidic part of the IDR is non-uniformly sensitive to temperature
throughout its sequence (Figure 3.1.9).
The decreased peak intensities observed for certain resonances of the spectrum recorded
o

at 45 C lead us to evaluate the IDR in a residue-specific way. Signals of the spectra recorded at
15 oC and 45 oC overlap with the signals of the 25 oC spectra. Which allowed reliable transfer of
the resonance assignments from Figure 3.1.8a. Analysis of relative peak intensities as a function
of temperature are quantified via calculating the ratio of the

15

N-HSQC signal intensities recorded

o

at 45 C over the intensity of the same resonances recorded at 15 oC or 25 oC for each residue
number (Figure 3.1.9c,d). A pattern emerged when comparing signal intensities at 45 oC and 15
o

C, in which the ratio values for assigned residues between positions 81 and 99 (average ±

standard deviation = 0.13 ± 0.11) were substantially lower than the ratios obtained for the
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remainder of the IDR (residues 100-115, average ± standard deviation = 0.64 ± 0.30) (Figure
3.1.9c). Similarly, when comparing the 45 oC and 25 oC peak intensity ratios it yielded a
comparable pattern. Values for positions 81-99 (0.07 ± 0.06) were considerably lower than those
for IDR residues 100-115 (0.28 ± 0.12). This temperature dependence on NMR signal intensity
ratios in the two IDR segments (positions 81-99 vs 100-115) are indicative of distinct IDR
segments with unique tumbling rates, conformational and or chemical exchange timescales.
These factors can be differentially impacted by the adjacent folded headpiece domain. This is a
novel non-uniform temperature effect observed in the IDR in the context of it bound to its native
C-terminal HP, only made possible with the use of segmental labeling via SML. Overall these
outcomes provide evidence that this method is a practical and valuable means to investigate
IDRs.

Figure 3.1.9 Temperature sensitivity in the 35-residue acidic segment of the villin 4 IDR.
Representative regions of 15N-HSQC NMR spectra (500 MHz, 1H frequency) for IDR-HP63 with
the IDR segmentally labeled with 15N isotopes recorded at (a) 45 oC (black) / 15 oC (red) and (b)
45 oC (black) / 25 oC (red). Spectra recorded at 15 oC and 45 oC were re-referenced to the 1H /
H2O chemical shift value (4.78 ppm) of the spectrum recorded at 25 oC according to a standard
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approach. The number of scans for the three spectra were 64 (15 oC), 128 (25 oC), and 192 (45
o
C), with 196 indirect increments ( 15N dimension) in all three cases. (c) Ratios of 15N-HSQC
backbone amide signal intensity for assigned IDR residues at 45 oC and 15 oC, and (d) a
corresponding data set for signal intensity ratios at 45 oC and 25 oC. In both panels (c) and (d),
data points for residues 81-99 are colored in light grey, and dark grey for residues 100-115. Light
grey and dark grey arrows on panels (a) and (b) point to select signals representing each of these
two respective groups. Data points for residues 87 (from the light grey group) and 106 (dark grey
group) are excluded from this analysis due to their resonance overlap. Data points for N-terminal
residues 78-80 are also excluded from the analysis since they can be subject to end effects.
Values shown above the brackets represent the average intensity ratio (± standard deviation) for
the residues indicated.

3.2 Segmental labeling of dematin toward investigating its binding interfaces
By applying the methodology piloted on villin 4 (V4) to dematin we further demonstrated
this method’s compatibility with studying large IDR containing proteins. Sortase-mediated ligation
(SML) generated segmentally labeled dematin could reduce spectral overlap that has hindered
the characterization of dematin’s non-covalent interface between its IDR and HP that occurs upon
phosphorylation at S381, which in turn inhibits its F-actin bundling capabilities.32,33 Characterizing
this interface could have huge implications for human health, as dematin is involved in many vital
cellular processes and disease states in our bodies.21,22,24,26–28 The ability to adapt SML to create
segmentally labeled dematin provides proof that this method could make studying these vital large
IDR containing proteins more practical.
Here we have developed a method to utilize SML to segmentally label dematin with NMR
active isotopes (15N). We have also optimized recombinant expression, solubilization and
stabilization providing increased yields compatible with SML and NMR. These methods could be
crucial for the characterization of dematin’s potential IDR-HP interface.

3.2.1 Dematin construct design
Toward our goal of creating a segmentally labeled dematin, we utilized Dr. Antos’s and
Dr. Smirnov’s program, SLIDRs, to search dematin’s wild type (WT) sequence for potential
locations that could be converted to a SML site (LPXTG) with 2 or less point mutations. This
program identified multiple potential sites that met these parameters (three are highlighted in
Figure 3.2.1 and shown in navy blue). We chose the most C-terminal LQSTE segment to mutate
to LPSTG with 2 point mutations (Q302P and E305G) (Figure 3.2.1). This location would allow
for the entirety of the HP (Figure 3.2.1, shown in yellow) to be treated independently of the IDR
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(figure 3.2.1, shown in teal) allowing SML to label the HP and IDR independently. In order to
investigate dematin not only in its native state (with unphosphorylated HP, DHP), but in its
phosphomimetic state (phosphomimetic HP, DPHP). To generate the phosphomimetic, we
utilized the S381E point mutation in its HP domain (Figure 3.2.1), which has been previously
shown to mimic phosphorylation at this site. 32,33

Figure 3.2.1 WT dematin sequence analyzed via SLIDRs for SML modification toward
segmentally labeling dematin. Dematin’s IDR domain is shown in teal while its folded HP
domain is shown in yellow for both the illustration and sequence representation of dematin. The
phosphorylation site of interest is marked with a black bold asterisk in the sequence
representation. The potential LPXTG sites for SML created by two or less point mutations are
shown it navy blue in the sequence representation.
Dematin with this S381E point mutation will hereafter be referred to as phosphomimetic
dematin (Figure 3.2.2a,b). Unphosphorylated dematin constructs (dematin with wild-type HP)
have the native S at residue 381 (Figure 3.2.2a,b). An affinity tag was engineered at dematin’s
N-terminus for purification purposes along with a TEV cleavage site for potential tag removal
(Figure 3.2.2a). All full length dematin sequences contain the two point mutations that create the
SML site LPSTG between its IDR and HP (Figures 3.2.1 and 3.2.2).
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Figure 3.2.2 Dematin construct design for SML. Dematin’s folded HP domain is shown in
yellow, its SML site is shown in navy, and its IDR is shown in teal attached to the TEV protease
cleavage site shown in purple with an N-terminal affinity tag shown in grey. (a) illustrated wildtype (WT) dematin shown above the dematin (with and without phosphomimetic HP) construct
engineered to undergo SML. (b) Pymol representation of WT dematin HP (DHP) shown in yellow
aligned with dematin’s phosphomimetic HP (DPHP) shown in cyan.
3.2.1.1 Full length dematin with FH8 tag (Dem and DemP)
Construct design
Full length dematin with and without the S381E mutation was engineered with a FH 8
solubility domain (FH8 tag) at its N-terminus for purification purposes along with a TEV cleavage
site for potential tag removal. These constructs were to serve as controls to test the impacts of
the mutations on dematin’s structure (15N-HSQC) and function (F-actin sedimentation assays).
They would also serve as controls for SML generated dematin that would be identical to these
constructs upon ligation.
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DemP and Dem preparation
Plasmids that encode for dematin constructs Dem and DemP were expressed in E.coli
and isolated from the lysate’s soluble fraction and solubilized from the cell’s inclusion bodies via
6 to 8 M urea. Recombinant expression (1L culture) provided NMR compatible yields (1 L culture
: ~758 mg (Dem lysate) and ~817 mg (DemP lysate)). These constructs were then dialyzed to 22
mM or 2 M urea and purified with their FH 8 tag, a handle for hydrophobic interaction
chromatography (HIC), giving greatly diminished yields that were not at the desired purity for
NMR. Dematin was further found to become insoluble upon urea removal. When Dem and DemP
(from a 1 L culture) were HIC purified in 2 M urea, it produced 1.5 mg and 2.6 mg of semi pure
protein (Figure 3.2.3). The construct also degraded rapidly, complicating its analysis and
quantification. A total level of 2-8 M urea increased the life span of these dematin constructs by
slowing degradation and was used for storage purposes, but also decreased purity obtained from
HIC purifications.

Figure 3.2.3 HIC purified Dem and DemP from 1 L Luria broth expression. (a) 15% SDSPAGE of Dem lysate (center lane) that was purified via HIC and yielded semi pure dematin seen
in the right lane. Molecular weight ladder was used to assess identity and purity of the sample
(left lane). (b) 15% SDS-PAGE of DemP lysate (center lane) that was purified via HIC and yielded
semi pure dematin seen in the right lane. Molecular weight ladder was used to assess identity
and purity of the sample (left lane).
15

N-HSQC spectra were recorded for both Dem and DemP (~1.2 mg

(degradation was present), and 2.6 mg

15

15

N Dem

N DemP) for a rough assessment of whether our point

mutations greatly perturbed dematin’s HSQC fingerprint. Dem and DemP were successfully
isotopically enriched, however Dem’s purity was poor and not at the level desired for NMR.

15

N

uniformly labeled Dem and DemP HSQC were recorded at 20 oC regardless (Figure 3.2.4). They
revealed some peaks as expected in the disordered region (7.8-8.7 ppm), and peaks for the folded
FH8 tag. However, the majority of dematin’s folded HP domain peaks were missing (Figure 3.2.4).
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The FH8 tag resonances are overlayed in red in Figure 3.2.4 in spectra (a) and (b). HP peaks
were not as prominent as expected for either construct. This could be due to the lack of
concentration and purity of the samples, or unexpected intramolecular dynamics between the HP
and FH8 tag.
Notably Dem’s HSQC only had a signature for one tryptophan residue; the FH8 domain
doesn’t contain any tryptophans, however, dematin’s HP contains one and its IDR contains 3,
thus we would expect four peaks, not one, at (~10 ppm (1H),~130 ppm (15N)) (Figure 3.2.4a).
DemP’s HSQC shows all four Trp peaks expected (Figure 3.2.4b). This unexpected
disappearance of tryptophans in Dem’s HSQC could be due to the FH8 tag interacting with
dematin, and unexpectedly changing the dynamics and or chemical environment of 3 out of the 4
tryptophans. This could explain their disappearance from the expected ppm range (Figure
3.2.4a). If the FH8 tag is to be utilized as an N-terminal affinity tag for dematin it must be TEV
cleaved to deduce its impact on dematin. These constructs were therefore retired due to the FH8
solubility domain’s inability to provide desired purity (for Dem) and its lack of compatibility with the
urea needed for solubilization, stabilization and storage of dematin.

Figure 3.2.4 Dem and DemP 15N-HSQC. (a) 15N-HSQC of Dem (black peaks) tag overlayed with
resonances for isolated FH8 shown with red boxes. SDS-PAGE of the NMR sample (15N-Dem) is
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shown on the far right. (b) 15N-HSQC of DemP (black peaks) tag overlayed with resonances for
isolated FH8 shown with red boxes. SDS-PAGE of the NMR sample (15N-DemP) is shown on the
far right.
3.2.1.2 Segmented dematin constructs with FH8 tag (DemIDR, G-DHP, G-DPHP)
Construct design
New constructs that would allow recombinant expression of either the C-terminal HP or
the N-terminal IDR (DemIDR) of dematin within E.coli were engineered for SML. Upon SML with
the N and C terminal constructs the ligation products form full length dematin identical to Dem or
DemP, depending on whether WT or Phosphomimetic HP were reacted (Figure 3.2.2c).
Segmented dematin constructs were thought to remedy the troubles observed when purifying
Dem and DemP. DemIDR was engineered with the 2 point mutations previously described to
create the LPSTG SML site. DemIDR also contained a N-terminal FH8 solubility domain
separated from the IDR by a TEV cleavage site for tag removal and a C-terminal His6-tag for
purification purposes (urea compatible). For the C-terminal ligation partner, dematin’s WT HP
(DHP) and phosphomimetic HP (DPHP) domains were engineered to have a N-terminal TEV
cleavage sites followed by a His6-tag. TEV cleavage of the His6-tag would reveal an exposed Nterminal glycine (G-DHP, G-DPHP) to serve as the nucleophile in the SML reactions of these
constructs.

Figure 3.2.5 SML with segmented dematin constructs. (a) Experimental schematic for the
generation of segmentally labeled Dem via SML. (b) Experimental schematic for the generation
of segmentally labeled Dem via SML.
DemIDR preparation
The plasmid encoding DemIDR was expressed in E.coli and isolated from the lysate’s
soluble fraction as well as solubilized from the cell’s inclusion bodies using 8 M urea (Figure
3.2.6a). Recombinant expression provided NMR compatible yields (1 L culture gave ~800 mg
(DemIDR lysate)). The construct was purified via IMAC (Ni-NTA) in 8 M urea and provided high
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purity and yields (95 mg of pure DemIDR from 1 L culture) that were beyond the desired
concentration for SML (Figure 3.2.6a).

G-DHP and G-DPHP preparation
Plasmids that encode DHP and DPHP were recombinantly expressed in E.coli and
isolated from the lysate’s soluble fraction as well as solubilized from the cell’s inclusion bodies
using 6 to 8 M urea (Figure 3.2.6b,c). Recombinant expression provided high yields (1 L culture
gave ~356 mg (DHP lysate) and ~387 mg (DPHP lysate)). These constructs were purified and
transitioned from 6 M to 0 M urea via IMAC (Ni-NTA) providing high purity and yields (1 L culture
gave 44 mg of pure DHP and 38 mg of pure DPHP). Both amounts were greater than the
concentration needed for SML (Figure 3.2.6b,c). These constructs were also successfully TEV
cleaved giving pure G-DHP and G-DPHP at yields compatible with SML and NMR (2.9 mg of pure
G-DHP and 2.1 mg of pure G-DPHP from 1 mL TEV cleavage reactions) (Figure 3.2.6b,c). LCESI-MS and SDS-PAGE confirmed the identity and purity of these proteins (Figure 3.2.6b,c).

Figure 3.2.6 DemIDR, G-DHP, G-DPHP preparation. (a) 15% SDS-PAGE of DemIDR IMAC
purified in 0 M urea vs 8 M urea. Degradation is less and yield is higher when prepped in the
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presence of urea. (b) schematic of G-DHP generation along with the corresponding 15% SDSPAGE and LC-ESI-MS to confirm purity and identity. (c) schematic of G-DPHP generation along
with the corresponding 15% SDS-PAGE and LC-ESI-MS to confirm purity and identity.
(15N)G-DHP and (15N)G-DPHP HSQC spectra
Both (15N)G-DHP and (15N)G-DPHP were prepped in the presence of urea and buffer
exchanged from urea as detailed in the methods section. This allowed solubilization of the HP
domains from the E.coli’s inclusion bodies increasing yields. The HP domain’s identity was
assessed with SDS-PAGE and LC-ESI-MS. The percentage of 15N incorporation was calculated
for both G-DHP (70% 15N incorporation) and G-DPHP (90% 15N incorporation) by comparing their
masses with the mass expected for 100%

15

N incorporation (Figure 3.2.7b,c). Here we

demonstrated that both HP domains refold upon urea removal, as seen by the peaks observed
outside the 7.8 - 8.7 ppm range associated with disorder (Figure 3.2.7a). Successful

15

N

enrichment of both DHP and DPHP allows them to serve as SML ligation partners for unlabeled
(14N) dematin IDR to create segmentally labeled dematin samples.

Figure 3.2.7 15N-HSQC of G-DHP overlayed on 15N-HSQC of G-DPHP. (a) 15N HSQC of 15N-GDHP in black overlayed on 15N HSQC of 1(15N)G-DPHP in red. (b) 15% SDS of (15N)G-DHP NMR
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sample and its mass spectrum. (c) 15% SDS of 15N-G-DPHP NMR sample and its mass spectrum.
Expected masses were calculated assuming 100% 15N incorporation.
The G-DHP and G-DPHP 15N-HSQC spectra indicated that they adopt the signature folds
reported for dematin’s WT and phosphomimetic HP domains upon urea removal. This is
demonstrated when G-DHP and G-DPHP spectra in black are overlayed with known backbone
resonances of dematin’s HP and phosphomimetic HP domains reported to BMRB, shown in red
boxes (Figure 3.2.8). Each spectra only differs significantly by 3 backbone resonances from what
is reported in the literature (not comparing sidechain peaks).33 These differences could be due to
the additional N-terminal glycine present in these samples and the different buffer conditions used
here than those of the samples from the BMRB entries 5968 and 6718. This knowledge allowed
urea to additionally be utilized for the stabilization of dematin’s IDR. While not investigated here,
the functionality of refolded HP could also be assessed via F-actin sedimentation assays.

Figure 3.2.8 G-DHP and G-DPHP 15N-HSQC overlayed with backbone resonances reported
in the literature (BMRB). (a) G-DHP 15N-HSQC shown in black overlayed with backbone
resonances for WT dematin HP (BMRB 5968) shown with red boxes. (b) G-DPHP 15N-HSQC
shown in black overlayed with backbone resonances for phosphomimetic dematin HP (BMRB
6718) shown with red boxes.
Segmented dematin SML creating Dem and DemP
G-DHP and G-DPHP were each successfully ligated to DemIDR via sortase stitching of
the C-terminus of DemIDR to the N-terminus of either G-DHP or G-DPHP. SML was conducted
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in 0 to 2 M urea and produced the desired ligation product. Maximal product formation was
achieved after 6 hours of reacting when urea was present to slow degradation (Figure 3.2.9).
However, purification with IMAC followed by HIC failed to isolate the ligation product (Figure
3.2.9). Lack of purity was consistent for what was achieved with HIC of full length dematin, Dem
and DemP. Thus, dematin IDR constructs and both full-length unphosphorylated dematin and
phosphomimetic dematin control samples were redesigned with new affinity tags replacing the
FH8 solubility domain. The new dematin IDR construct (DISH) was then able to serve as the SML
ligation partner to G-DHP and G-DPHP, and create a ligation product identical to full length
unphosphorylated dematin (DS) and phosphomimetic dematin (DPS). The key to this new design
was the use of a new urea-compatible affinity tag (dual strep tag) that replaced the FH8 solubility
domain at the N-terminus.

Figure 3.2.9 SML generated Dem and DemP. (a) Schematic of SML reaction for the generation
of Dem and the corresponding 15% SDS-PAGE for that reaction completed in 0 and 2 M urea at
room temperature for 3 to 6 hours. The 15% SDS-PAGE also shows the failed isolation of the
ligated product in 0 M urea (IMAC followed by HIC). (b) Schematic of SML reaction for the
generation of DemP and the corresponding 15% SDS-PAGE for that reaction completed in 0 and
2 M urea at room temperature for 3 to 6 hours. The 15% SDS-PAGE also shows the failed
isolation of the ligated product in 0M urea (IMAC followed by HIC).
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3.2.1.3 Dual strep tagged full length dematin with (DPS) and without (DS) the
phosphomimetic HP controls.
Construct design
Full length dematin with and without the S381E mutation were engineered with a Nterminal dual strep tag domain for purification purposes along with a TEV cleavage site for
potential tag removal. The constructs also contained the two IDR point mutations that created the
LPSTG SML site located in the same position seen in Dem and DemP. A dual strep tag is
compatible with up to 6 M urea, which is valuable for the use of urea to solubilize and stabilize full
length dematin. These constructs served as controls to test if the mutations made disrupt the
structure or IDR-HP interface seen in the phosphomimetic dematin. These constructs also served
as controls for SML generated dematin and can assess the mutation’s functional impact on
dematin via F-actin sedimentation assays.

Strep tagged DS and DPS preparation
Plasmids that encoded for dematin constructs DS and DPS were expressed in E.coli and
isolated from the lysate’s soluble fraction as well as solubilized from the cell’s inclusion bodies
using 6 M urea. Recombinant expression provided NMR compatible yields (1 L expression gave
~374 mg of DS and ~372 mg of DPS). These constructs were then purified out of 6 M into 0 M
urea with Strep-Tactin®XT resin, which provided the desired concentration and purity for NMR:
12.8 mg of pure DS and 10.6 mg of pure DPS (Figure 3.2.10). The constructs also underwent
SEC as needed at a flow rate of 0.2 to 0.5 mL/min if the sample was degraded. Urea (2 to 6 M)
increased the constructs’ life span by slowing degradation and was used for storage of the
constructs for periods of a week or more. The dual strep tag served as a means to remove urea
from the proteins by binding it to the Strep-Tactin®XT resin and washing it with buffer that lacked
urea. PMSF at 1 mM final concentration and 4 oC also slowed degradation when 0 M urea was
not present. The construct was assessed with LC-QTOF-MS and the desired mass was observed
upon the addition of 1 mM TCEP to dislodge E.coli’s endogenous glutathione, which remains
covalently bound to a cysteine of dematin’s IDR until exposed to reducing agents (Figure 3.2.10).
Together this provided evidence that this new construct design with a dual strep tag provides pure
dematin that is urea compatible and can serve as a control for DS and DPS generated through
SML, as well as to check the impact of the mutations on dematin’s structure and function.
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Figure 3.2.10 DS and DPS preparation. (a) 15% SDS-PAGE of DS and corresponding mass
spectrum. (b) 15% SDS-PAGE of DPS and corresponding mass spectrum.
15

N-HSQC of strep tagged unphosphorylated dematin (DS) and phosphomimetic dematin (DPS)
DS and DPS were both successfully enriched with

15

N as confirmed via NMR and LC-

15

QTOF-MS (Figure 3.2.11). N enrichment for DS was around 97% incorporation when compared
with the mass expected for 100%

15

N incorporation (Figure 3.2.11a). (15N)DS was expressed in

1 L of minimal media (from 6 L LB, see methods) yielding 1850.1 mg DS (lysate) that was purified
to 11 mg pure DS (only 1.9 mg were assessed via NMR to avoid insolubility).

15

N enrichment for

DPS was around 95% incorporation when compared with the mass expected for 100%
incorporation (Figure 3.2.11b). (15N)DPS was expressed in 1 L of minimal media (from 6 L LB,
see methods) yielding 1842.5 mg (lysate) that was purified to 10.4 mg of pure DPS (only 1.7 mg
were assessed via NMR to avoid insolubility). Yields could be improved by increasing the amount
of Strep-Tactin®XT resin utilized, as indicated by the flowthrough for both constructs containing
greater than 800 mg of protein, which can be re-exposed to Strep-Tactin®XT resin. This was not
necessary because yields were sufficient for NMR. However, if one were to TEV cleave the dual
strep tag off dematin the yields can easily be increased to be compatible with TEV cleavage
reactions.
15

N-HSQC of DS and DPS uniformly labeled with 15N reveals HP peaks seen for both WT

and phosphomimetic dematin, indicating that the HP refolds into its characteristic shape within
full length dematin upon urea removal (Figure 3.2.11). Notably, some additional peaks thought
to be from the dual strep tag were observed (additional 6 glycines and 2 tryptophans) in both
(15N)DS and (15N)DPS HSQC spectra (Figure 3.2.11). TEV cleavage of the dual strep tag would
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reveal if the additional peaks seen in both DS and DPS 15N-HSQC spectra are from the dual strep
tag. Interestingly, tryptophan residues are seen in both DS and DPS

15

N-HSQCs (~10 1H ppm,

~13015N ppm) (Figure 3.2.11c,d) no matter S381E mutation’s presence. This is unlike what was
observed when the FH8 tag was present in place of the dual strep tag (Figure 3.2.4). We can
hypothesize that the FH8 domain was not acting independently of dematin, but instead interacting
with dematin’s HP and IDR tryptophans causing their signature to differ from what was expected
(Figure 3.2.4 and Figure 3.2.11). Likewise, the two tryptophan’s of the dual strep tag could also
be interacting with the tryptophans of dematin’s IDR and HP, disrupting or weakening the IDRphosphomimetic HP interface. Which, could explain why the HP peaks are visible even in the
presence of the S381E mutation in DPS, unlike what was reported in the literature. Another
explanation for the observed phosphomimetic HP signatures could be due to the higher
concentrations than what was achieved in the literature (1.7 to 1.9 mg here versus the 0.5 to 1.2
mg reported in the literature), allowing observation of the phosphomimetic HP signatures while
interfacing with the IDR. These hypotheses could be tested via TEV cleavage of the dual strep
tag and recording the tag free sample’s 15N-HSQC.

Figure 3.2.11 15N-HSQC spectra of uniformly labeled DS and DPS and their corresponding
mass spectra and 15% SDS-PAGE. (a) (15N)DS HSQC and corresponding mass spectra and
15% SDS-PAGE for the NMR sample. (b) (15N)DPS HSQC and corresponding mass spectra and
15% SDS-PAGE for the NMR sample.
As a preliminary attempt to investigate if the phosphomimetic HP peaks seen are due to
higher yields allowing the HP to be observed in a state of IDR interaction, we analyzed HSQC
spectra of full length dematin and its corresponding isolated HP (WT and phosphomimetic). We
overlayed the HSQC spectrum of full length strep tagged dematin with the phosphomimetic HP
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(DPS) with the HSQC spectrum of isolated phosphomimetic HP (G-DPHP) (Figure 3.2.12b).
Likewise, we overlayed the HSQC spectrum of full length strep tagged dematin with WT HP (DS)
with the HSQC spectrum of isolated WT HP (G-DHP) (Figure 3.2.12a). We then could control for
the changes caused by the phosphomimetic mutation known in the literature (and seen in our HP
constructs) to see if peaks differ between our isolated HP spectra and HP resonances in full length
dematin with and without the S381E mutation in the context of the IDR. This allowed the
identification of residues potentially binding the IDR in the presence of the S381E mutation. This
is only a partial picture of the phosphomimetic HP residues impacted by the IDR’s presence
because many HP peaks are obscured via spectral overlap from the IDR’s resonances within the
ppm region associated with disorder.
However, the above analysis does reveal some changes seen only in strep tagged
phosphomimetic dematin, potentially implicating residues for interacting with the strep tagged
IDR. Phosphomimetic HP residue Leu63’s HSQC peak volume decreases disproportionally when
in the presence of the IDR. Which, is not observed for this residue without the IDR (isolated
phosphomimetic HP) nor when the WT HP and the IDR are present (Figure 3.2.12c,d). HSQC
peak volume is indicative of intramolecular dynamics, such as rates of binding and unbinding.
Values for peak volume were calculated in each spectra for a random selection of well resolved
HP peaks (without spectral overlap). Peak volume ratios were then calculated for each of these
residues via dividing peak volumes of each residue in full length dematin by its corresponding HP
peak volume in the isolated HP spectra. These ratios were plotted for each of these residues on
a bar graph for each spectra overlay. (Figure 3.2.12g). Leu63’s (PDB 1ZV6 numbering) peak
volume ratio decreased dramatically upon the presence of the phosphomimetic mutation, which
was unobserved for full length dematin with WT HP. Implicating phosphomimetic HP as
interacting with the strep tagged IDR (Figure 3.2.12g). Likewise, another unique change seen in
full length phosphomimetic dematin is that the HP peak for Tyr22 (PDB 1ZV6 numbering)
experiences a significant

N ppm shift of 0.47 ppm when compared to Tyr22’s HSQC signature

15

in phosphomimetic HP in isolation (Figure 3.2.12f).

15

N ppm shifts of greater than 0.2 ppm are

accepted in the literature as significant and associated with chemical environment changes. The
same Tyr22 residue (PDB 1QZP numbering) of WT HP in full length dematin when compared to
the WT HP in isolation experiences an insignificant ppm shift of 0.12 ppm (Figure 3.2.12e). The
changes seen for Tyr22 and Leu63 only occur in the presence of both the IDR and the
phosphomimetic mutation indicating a potential structural shift occurring in phosphomimetic
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dematin that needs further investigation. Interestingly, these residues are not directly adjacent to
where the IDR connects to the HP (Figure 3.2.12h). The cleavage of the strep tag is therefore
essential to glean if these changes observed in phosphomimetic dematin HP are due to the IDRHP interface, now visible at higher dematin yields. Or if the changes are from the non-native dual
strep tag interacting with phosphomimetic dematin’s HP hindering the IDR-HP interface and
allowing its visualization. This analysis is greatly hindered by spectral overlap characteristic of
dematin’s large IDR. However, even with this hinderance some notable unique changes were still
observed within phosphomimetic dematin that call for additional investigation. Segmental labeling
of dematin would reduce the spectral overlap that is obscuring the HP within the disordered ppm
region, and therefore allow a complete assessment and potential characterization of the HP-IDR
interface expected in the presence of the S381E mutation.

Figure 3.2.12 15N-HSQC spectra of unphosphorylated and phosphomimetic dematin
overlayed with 15N-HSQC of their corresponding isolated HP. (a) (15N)DPS HSQC overlayed

49

with (15N)G-DPHP HSQC. (b) (15N)DS HSQC overlayed with ( 15N)G-DHP HSQC. (c) and (d) show
resonances of Leu63. (e) Shows resonances of Tyr22 in unphosphorylated dematin (DS)
overlayed with resonances of isolated WT HP (G-DHP). (f) Shows resonances of Tyr22 in
phosphomimetic dematin (DPS) overlayed with resonances of isolated phosphomimetic HP (GDPHP). (g) Shows the volume ratio calculated between DS/G-DHP and DPS/G-DPHP for a
random sample of well resolved HP peaks within these spectra. (h) Shows Pymol representation
of Leu63 and Tyr22 along the S381E mutation site and the HP’s N-terminus.
Segmentally labeling dematin could be achieved through SML with a N-terminal IDR
construct as discussed previously for DemIDR, but in place of its N-terminal FH8 tag a dual strep
tag would be used. Thus, SML of this new

14

N dematin IDR construct, (DISH), with ( 15N)G-DHP

or (15N) G-DPHP would generate segmentally labeled strep tagged full length unphosphorylated
dematin (DS) or strep tagged full length phosphomimetic dematin (DPS) (Figure 3.2.13) identical
to the dematin control constructs discussed in Figures 3.2.11 and 3.2.12.

3.2.1.4 Dual strep and His tagged N-terminal half of dematin (IDR) for SML (DISH)
Construct design
DISH is a re-designed DemIDR construct containing dematin’s IDR with the two point
mutations creating the LPSTG SML site attached to an N-terminal dual strep tag (replacing the
FH8 solubility domain) followed by a TEV cleavage site for potential tag removal and a C-terminal
His6-tag (Figure 3.2.13). The new design is compatible with urea and thus will allow us to
solubilize, purify, stabilize, store, perform SML, and isolate the ligation product, all in the presence
of urea.

DISH preparation
The plasmid encoding DISH was expressed in E.coli and isolated from the lysate’s soluble
fraction as well as solubilized from the cell’s inclusion bodies using 6 M urea (Figure 3.2.13).
Recombinant expression provided SML compatible yields (1 L expression gave 394 mg (DISH
lysate)). The construct was purified via IMAC (Ni-NTA) in 6 M urea followed by strep purification
in either 6 M, 2 M, or 0 M urea, providing high purity and yields at 14 mg of pure DISH that were
at the required concentration for SML and NMR (Figure 3.2.13). Yields could potentially be
improved by increasing the Strep-Tactin®XT resin utilized as indicated by the flowthrough still
containing greater than 200 mg of protein than can be re-exposed to Strep-Tactin®XT resin. The
purity and identity of the construct was assessed with SDS-PAGE and LC-QTOF-MS, and the
desired mass was observed upon the addition of 1 mM TCEP to dislodge E.coli’s endogenous
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glutathione, which remains covalently bound to a cysteine of dematin’s IDR until exposed to
reducing agents. Successful preparation of dematin’s N-terminal half (DISH) provides the needed
SML reactant for creating full length dematin upon ligation with dematin’s HP (G-DHP, G(D-PHP).

Figure 3.2.13 Strep and His tagged dematin IDR (DISH) preparation. Schematic of how SML
can utilize DISH to make full length dematin constructs along with the corresponding 15% SDSPAGE of DISH’s recombinant expression, purification (IMAC followed by strep purification) and
identification via LC-QTOF-MS.
3.2.2 Generating strep tagged dematin (DS) and phosphomimetic dematin (DPS) with
SML
A model SML reaction using 5 µM SrtA7M to catalyze the ligation of 10 µM DISH to either
50 µM G-DHP or G-DHP was performed on 600 µL scale in the presence of 2 M urea (final reagent
concentrations listed). The reaction incubated for 4 hours at 4 oC, where it was then spiked with 6
M urea to halt the reaction and slow degradation of the product. It should be noted that sortase is
active in up to 2 M urea. The reaction yielded the formation of the expected ligation product
(Figure 3.2.14), demonstrating that DISH is a compatible N-terminal ligation partner for SML with
G-DHP or G-DPHP. This serves as a proof of concept that SML can generate DS and DPS,
potentially allowing for the formation of segmentally labeled dematin.
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Figure 3.2.14 Generating DS and DPS with SML. (a) Schematic for SML between G-DHP and
DISH and corresponding 15% SDS-PAGE of G-DHP and DISH SML in 2 M urea at 4 oC for 4
hours. (b) Schematic for SML between G-DPHP and DISH and corresponding 15% SDS-PAGE
of G-DPHP and DISH SML in 2 M urea at 4 oC for 4 hours.
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3.2.3 Generating segmentally labeled DPS (phosphomimetic dematin) with SML
SML of 50 µM (15N)G-DPHP, 5 µM SrtA7M and 10 µM of (14N)DISH in 2 M urea was completed on
a 2 mL scale. The reaction incubated for 6 hours at 4 oC, yielding the desired ligation product. The
reaction was then spiked with 6 M urea to halt the reaction and slow degradation of the product
(Figure 3.2.15a). The ligation product was successfully isolated via IMAC in 6 M urea followed
by strep purification from 6 M to 0 M urea (Figure 3.2.15b). The identity of the segmentally labeled
ligated product, (14N)DISH-(15N)DPHP, was assessed via LC-QTOF-MS, revealing a mass that
was consistent with the calculated expected molecular weight. The expected molecular weight for
this segmentally labeled ligation product was determined via assuming 100%

15

N incorporation

within only the HP domain of the ligated product. Overall, we isolated 0.04 mg of the segmentally
labeled product, which indicates only about 5% yield. However, this reaction can be optimized for
timing of maximal ligation product formation and scaled up to provide greater yields. The
purification scheme can also be optimized; some residual ligated product was lost due to
insufficient washing of the IMAC resin (some ligated product still present in the IMAC elution).
Increasing the amount of Strep-Tactin®XT resin used could also help increase yields, as it was
observed that some of the ligated product was still present in the strep purification flowthrough
fraction. Regardless, this experiment provides proof of concept that SML can generate
segmentally labeled dematin constructs that can be isolated. Together this provides evidence that
segmentally labeling dematin can be accomplished, potentially providing a method to characterize
phosphomimetic dematin’s IDR-HP interface that could aid in our understanding of
phosphorylated dematin’s inability to bundle F-actin. A mechanism pertinent to human health and
thus our ability to design therapeutics to better combat the many disease states associated with
dematin’s critical functions within our bodies.
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Figure 3.2.15 Generating segmentally labeled DPS with SML. (a) 15% SDS-PAGE of SML
between 14N DISH and 15N G-DPHP at 0, 3 and 6 hour time points (lanes 2-4) and controls (lanes
5 through 10) confirming ligation product formation. (b) 15% SDS-PAGE of ligation product
isolation after 6 hours of reacting via IMAC in 6 M urea followed by strep purification for IMAC
flowthrough (FT) and wash (W) fractions from 6 M to 0 M urea. Successful isolation is seen in the
last lane (strep purification elution (strep E)) of the SDS-PAGE. (c) LC-QTOF-MS of Strep E
elution confirmed the ligation products identity.
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Section 4. Conclusion
In summary we have developed a method of employing sortase-mediated ligation (SML)
to create segmentally labeled proteins with sizable intrinsically disordered regions (IDRs) as seen
for both plant cytoskeleton regulating protein villin 4 (V4) and human dematin. SML proved to be
successful for both these vital IDR containing proteins to provide efficient ligations with high
specificity. Notably, V4 SML optimization included the finding that oligopeptides directly Nterminal to the LPXTG site can have a severe impact on ligation reaction rates and yield. This
was resolved for V4 by tuning the SML site’s environment to ensure efficient and reliable ligations.
SML of dematin proved to be efficient and reliable as well, however, degradation of dematin’s IDR
was impacting yields and purity. Thus SML was employed on dematin in 2 M urea, reducing
dematin degradation while allowing successful ligation product formation and segmental labeling.
SML was able to generate segmentally labeled (15N and or
were segmentally labeled with

15

N and

13

13

C) proteins. V4 derivatives

C isotopes for NMR characterization. Segmentally

labeling the 35-residue acidic segment of the IDR with isotopes allowed reliable identification of
the IDR backbone resonances via a process we have termed segmental assignment. Segmental
assignment relates a group of NMR resonances to a specific selectively labeled region within the
remaining unlabeled protein. These collective resonances were analyzed and identified as V4’s
IDR. The reliability of segmental assignment was assessed with residue-specific assignment of
the target region, using a minimal set of heteronuclear 3D NMR data. Comparisons of related
constructs with or without non-native features (sortase ligation site, FH8 tag, TEV protease site)
demonstrated minimal perturbations of the spectral signature of the target IDR. Dematin was
isotopically segmentally labeled with
with dematin’s

14

15

N via reacting labeled

15

N phosphomimetic HP (G-DPHP)

N unlabeled IDR (DISH) in 2 M urea. The segmentally labeled ligation product

was successfully isolated from the reaction mixture and its identity was confirmed with SDS-PAGE
and LC-QTOF-MS. This same method could be employed to create ( 15N)DHP-(14N)DISH via
reacting labeled 15N WT HP (G-DHP) with 14N IDR (DISH). The potential to create this derivative
of segmentally labeled dematin was demonstrated via the ability to create

15

N WT dematin HP

(G-DHP), as well as successful SML of 14N derivatives of WT dematin HP (G-DHP) with dematin’s
14

N unlabeled IDR (DISH) in 2 M urea.

The utility of SML created segmentally labeled intrinsically disordered proteins was
demonstrated for with V4. SML created segmentally labeled V4 (15N)IDR-(14N)HP63 and allowed
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the acidic 35-residue C-terminal portion of V4’s IDR to be assessed for temperature sensitivity.
This revealed that this segment of V4’s IDR is non-uniformly temperature sensitive. Despite these
findings being from truncated V4’s IDR (35 residues), it still suggests the full 190 residue IDR
might possess regions of distinct dynamics and transient structure. Thus, much remains to be
investigated about V4’s IDR. SML generated segmental labeling could make this analysis
possible, opening the door to groundbreaking discoveries for the field of agriculture that could
help combat world hunger.
The value of SML created segmentally labeled intrinsically disordered proteins was further
demonstrated with its application on dematin. This vital large IDR containing protein is
understudied due to its 315 residue IDR. The non-covalent interface between its IDR and HP
hypothesized to form in the presence of phosphorylation and the S381E mutation is
uncharacterized due to severe spectral overlap. This IDR-HP interface is thought to be the cause
for phosphorylated dematin’s inability to bundle F-actin. With uniformly labeled dematin we are
able to deduce potential residues of the HP domain, Tyr22 and Leu63 (PDB 1QZP/1ZV6
numbering), that experience changes in chemical environments and intramolecular dynamics
when only in the presence of the IDR and the S381E mutation, suggesting these residues interact
with the dual strep tagged IDR. However, the analysis is incomplete due to much of the HP peaks
being obscured by severe spectral overlap from dematin's IDR. The creation of full length
segmentally labeled dematin in which only the HP possesses

15

N enrichment would reduce the

spectral overlap and allow visualization and analysis of all HP peaks with the IDR still present.
This can be done for the HP with and without the S381E mutation. These samples’ HSQC spectra
could potentially allow for characterization of the HP-IDR interface. This characterization should
be done in the absence of the dual strep tag to ensure it is not disrupting or changing the IDR’s
interaction with the phosphomimetic HP. Another aspect that this method can aid with is
investigating native phosphorylation at S381, which is possible by exposing only the

15

N G-DHP

to PKA for phosphorylation of only the HP. This phosphorylated HP could then be ligated to

14

N

dematin IDR and the interface could be characterized in terms of native phosphorylation at S381.
Additionally, the impact of urea on the fold of HP could be further investigated. Here, it was
assessed via comparisons of our HP domains with the reported BMRB assignments, but
additional functional studies of dematin could be conducted to see if it can still bind and bundle
F-actin as reported in the literature. Notably, dematin’s HP and chicken villin’s HP were purified
in the literature with HPLC under denaturing conditions and were still reported to function as
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expected with regards to F-actin binding upon refolding.32,33,46 SML generated segmentally
labeled dematin provides a novel method to analyze dematin, potentially opening the door to
structural and dynamic analysis of full length dematin that can allow IDR-HP interface
characterization. Discoveries of how dematin is regulated and what residues are key could help
aid therapeutic design for the multitude of diseases in which dematin is implicated.
This work reveals the value and practicality of SML generated segmentally labeled
proteins with large IDRs. Segmental assignment of V4 was accomplished with ease compared to
the typical process for analysis of proteins with IDRs, where many acquisitions of 3D and 4D
heteronuclear NMR data are needed, requiring NMR experiments with higher magnetic fields
(limited facilities) and longer recording times beyond the lifespan of many IDRs.47–49 Here,
segmental assignment of villin 4 was accomplished with expedient 2D NMR recordings that aided
identification of IDR regions of interest, revealing areas where residue-specific analysis would be
beneficial. Residue-specific analysis can be achieved with basic heteronuclear 3D NMR where
less experiments were sufficient for residue-specific assignment and analysis, resulting in
substantially reduced NMR acquisition times that are highly valuable and compatible with IDRs’
short lifespan. This was demonstrated with the

15

N-HSQC spectrum of V4 utilized for segmental

assignment, which was recorded in under 2 hours on a basic 500 MHz ( 1H frequency) NMR
spectrometer with a standard room temperature smart probe. Likewise, for residue-specific
assignment of V4’s IDR, only four straightforward 3D NMR experiments were needed (HNCACB,
CBCA(CO)NH, HNCO, HN(CA)CO) and were performed with a single preparation of the sample,
ensuring data consistency. The work with V4 provides proof of concept that such analysis can be
conducted on dematin and other protiens with large IDRs with short lifespans.

Overall, this methodology offers a practical means to analyze the many vital proteins with
large IDRs. SML could be utilized to not only selectively incorporate isotopes, but to add other
labels such as fluorophores and post-translational modifications. Additionally, dematin’s 300
residue IDR and V4’s 190 residue IDR, along with other known IDR sequences, can be assessed
for multiple sites compatible with forming an LPXTG site with two or less point mutations. More
SML sites utilized can broaden the range of segmentally labeled derivatives made allowing for
finer analysis of various IDR regions. These segmentally labeled IDR containing proteins can be
analyzed with

15

N-HSQC spectra recorded under various conditions: temperature, pH, salt

concentrations (electrostatics), as well as varying protein concentrations. This would allow us to
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probe the IDRs sensitivities to these factors. Understanding how these factors impact IDRs would
aid in our understanding of how IDRs function and could lead to groundbreaking discoveries
across disciplines due to IDRs prevalence in eukaryotic proteins, governing many crucial aspects
of life.

Abbreviations
IDR, intrinsically disordered region; SML, sortase-mediated ligation; NMR, nuclear magnetic
resonance; HSQC spectra, heteronuclear single quantum coherence spectra; LC-ESI-MS, liquid
chromatography

electrospray

ionization

mass

spectrometry,

LC-QTOF-MS,

Liquid

chromatography quadrupole time-of-flight mass spectrometry. For construct abbreviations see
methods section 2.2
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Appendix
Section 1 Protein constructs’ amino acid sequences
1.1 A. thaliana villin 4 constructs’ amino acid sequences:
FH8-IDR-HP63 (full length fusion of villin 4 IDR (residues 877-911) and HP63, generated either
through expression of full length protein or via sortase-mediated ligation of FH8-IDR-G and G2HP63; all contain single G spacer between IDR and LPXTG motif)
PSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSI
LSSGTSENLYFQGEEKKENDKEEGSMSSRIESLTIQEDAKEGVEDEEDGLPETGGLPAHPYDR
LKTTSTDPVSDIDVTRREAYLSSEEFKEKFGMTKEAFYKLPKWKQNKFKMAVQLF
IDR-HP63 (full length fusion of villin 4 IDR (residues 877-911) and HP63, generated either
through sortase-mediated ligation of FH8-IDR-G and G2-HP63; all contain single G spacer
between IDR and LPXTG motif and had FH8 solubility domain cleaved from the IDR)
GEEKKENDKEEGSMSSRIESLTIQEDAKEGVEDEEDGLPETGGLPAHPYDRLKTTSTDPVSDID
VTRREAYLSSEEFKEKFGMTKEAFYKLPKWKQNKFKMAVQLF
His6-IDR-HP63 (control sample lacking sortase LPXTG motif, TEV cleavage site and FH8
domain)
MHHHHHHEEKKENDKEEGSMSSRIESLTIQEDAKEGVEDEEDLPAHPYDRLKTTSTDPVSDID
VTRREAYLSSEEFKEKFGMTKEAFYKLPKWKQNKFKMAVQLF
TEV-G2-HP63
MHHHHHHENLYFQGGLPAHPYDRLKTTSTDPVSDIDVTRREAYLSSEEFKEKFGMTKEAFYKL
PKWKQNKFKMAVQLF
G2-HP63 (generated via TEV protease cleavage of TEV-HP63)
GGLPAHPYDRLKTTSTDPVSDIDVTRREAYLSSEEFKEKFGMTKEAFYKLPKWKQNKFKMAVQ
LF

FH8-IDR (initiator methionine absent in purified protein)
PSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSI
LSSGTSENLYFQGEEKKENDKEEGSMSSRIESLTIQEDAKEGVEDEEDLPETGGHHHHHH
FH8-IDR-G (initiator methionine absent in purified protein)
PSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSI
LSSGTSENLYFQGEEKKENDKEEGSMSSRIESLTIQEDAKEGVEDEEDGLPETGGHHHHHH
FH8-IDR-G3 (initiator methionine absent in purified protein)
PSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSI
LSSGTSENLYFQGEEKKENDKEEGSMSSRIESLTIQEDAKEGVEDEEDGGGLPETGGHHHHH
H
FH8-IDR-(G4S)2 (initiator methionine absent in purified protein)
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PSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSI
LSSGTSENLYFQGEEKKENDKEEGSMSSRIESLTIQEDAKEGVEDEEDGGGGSGGGGSLPET
GGHHHHHH
FH8-EDEED(initiator methionine absent in purified protein)
PSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSI
LSSGTS ENLYFQGGGGGSGGGGSEDEEDLPETGGHHHHHH
FH8 (generated via TEV protease cleavage of FH8-IDR-G)
PSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSI
LSSGTSENLYFQ
1.2 Dematin constructs’ amino acid sequences:
Dem (Full length dematin with WT HP engineered with a sortase LPSTG motif and a N-terminal
FH8 fusion tag, initiator methionine absent in purified protein)
PSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSI
LSSGTSENLYFQGERLQKQPLTSPGSVSPSRDSSVPGSPSSIVAKMDNQVLGYKDLAAIPKDK
AILDIERPDLMIYEPHFTYSLLEHVELPRSRERSLSPKAAAGGGAGKVWADSRSPGIISQASAPR
TTGTPRTSLPHFHHPETSRPDSNIYKKPPIYKQRESVGGSPQTKHLIEDLIIESSKFPAAQPPDP
NQPAKIETDYWPCPPSLAVVETEWRKRKASRRGAEEEEEEEDDDSGEEMKALRERQREELSK
VTSNLGKMILKEEMEKSLPIRRKTRSLPDRTPFHTSLHQGTSKSSSLPAYGRTTLSRLPSTGFS
PSGSETGSPGLQIYPYEMLVVTNKGRTKLPPGVDRMRLERHLSAEDFSRVFAMSPEEFGKLAL
WKRNELKKKASLF
DemP (Full length dematin with the phosphomimetic HP (S381E) engineered with a sortase
LPSTG motif and a N-terminal FH8 fusion tag, initiator methionine absent in purified protein)
PSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSI
LSSGTSENLYFQGERLQKQPLTSPGSVSPSRDSSVPGSPSSIVAKMDNQVLGYKDLAAIPKDK
AILDIERPDLMIYEPHFTYSLLEHVELPRSRERSLSPKAAAGGGAGKVWADSRSPGIISQASAPR
TTGTPRTSLPHFHHPETSRPDSNIYKKPPIYKQRESVGGSPQTKHLIEDLIIESSKFPAAQPPDP
NQPAKIETDYWPCPPSLAVVETEWRKRKASRRGAEEEEEEEDDDSGEEMKALRERQREELSK
VTSNLGKMILKEEMEKSLPIRRKTRSLPDRTPFHTSLHQGTSKSSSLPAYGRTTLSRLPSTGFS
PSGSETGSPGLQIYPYEMLVVTNKGRTKLPPGVDRMRLERHLSAEDFSRVFAMSPEEFGKLAL
WKRNELKKKAELF
DHP( Dematin’s WT HP separated from a N-terminal His6-tag via a TEV cleavage site)
MHHHHHHENLYFQGFSPSGSETGSPGLQIYPYEMLVVTNKGRTKLPPGVDRMRLERHLSAED
FSRVFAMSPEEFGKLALWKRNELKKKASLF
G-DHP (Dematin’s WT HP with a N-terminal glycine generated via TEV protease cleavage of
DHP)
GFSPSGSETGSPGLQIYPYEMLVVTNKGRTKLPPGVDRMRLERHLSAEDFSRVFAMSPEEFG
KLALWKRNELKKKASLF
DPHP (Dematin’s phosphomimetic HP separated from a N-terminal His6-tag via a TEV cleavage
site)
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MHHHHHHENLYFQGFSPSGSETGSPGLQIYPYEMLVVTNKGRTKLPPGVDRMRLERHLSAED
FSRVFAMSPEEFGKLALWKRNELKKKAELF
G-DPHP (Dematin’s phosphomimetic HP with a N-terminal glycine, generated via TEV protease
cleavage of DPHP)
GFSPSGSETGSPGLQIYPYEMLVVTNKGRTKLPPGVDRMRLERHLSAEDFSRVFAMSPEEFG
KLALWKRNELKKKAELF
DemIDR (Dematin’s IDR with a N-terminal FH8 fusion tag (cleavable via TEV) and a C-terminal
His6-tag cleavable via Sortase LPSTG motif, initiator methionine absent in purified protein)
PSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSI
LSSGTSENLYFQGERLQKQPLTSPGSVSPSRDSSVPGSPSSIVAKMDNQVLGYKDLAAIPKDK
AILDIERPDLMIYEPHFTYSLLEHVELPRSRERSLSPKAAAGGGAGKVWADSRSPGIISQASAPR
TTGTPRTSLPHFHHPETSRPDSNIYKKPPIYKQRESVGGSPQTKHLIEDLIIESSKFPAAQPPDP
NQPAKIETDYWPCPPSLAVVETEWRKRKASRRGAEEEEEEEDDDSGEEMKALRERQREELSK
VTSNLGKMILKEEMEKSLPIRRKTRSLPDRTPFHTSLHQGTSKSSSLPAYGRTTLSRLPSTGHH
HHHH
DS (Full length dematin with WT HP engineered with a sortase LPSTG motif and a N-terminal
dual strep tag)
MWSHPQFEKGSGGASWSHPQFEKGGGENLYFQSERLQKQPLTSPGSVSPSRDSSVPGSPS
SIVAKMDNQVLGYKDLAAIPKDKAILDIERPDLMIYEPHFTYSLLEHVELPRSRERSLSPKAAAGG
GAGKVWADSRSPGIISQASAPRTTGTPRTSLPHFHHPETSRPDSNIYKKPPIYKQRESVGGSP
QTKHLIEDLIIESSKFPAAQPPDPNQPAKIETDYWPCPPSLAVVETEWRKRKASRRGAEEEEEE
EDDDSGEEMKALRERQREELSKVTSNLGKMILKEEMEKSLPIRRKTRSLPDRTPFHTSLHQGT
SKSSSLPAYGRTTLSRLPSTGFSPSGSETGSPGLQIYPYEMLVVTNKGRTKLPPGVDRMRLER
HLSAEDFSRVFAMSPEEFGKLALWKRNELKKKASLF
DPS (Full length dematin with the phosphomimetic HP (S381E) engineered with a sortase
LPSTG motif and a N-terminal dual strep tag).
MWSHPQFEKGSGGASWSHPQFEKGGGENLYFQSERLQKQPLTSPGSVSPSRDSSVPGSPS
SIVAKMDNQVLGYKDLAAIPKDKAILDIERPDLMIYEPHFTYSLLEHVELPRSRERSLSPKAAAGG
GAGKVWADSRSPGIISQASAPRTTGTPRTSLPHFHHPETSRPDSNIYKKPPIYKQRESVGGSP
QTKHLIEDLIIESSKFPAAQPPDPNQPAKIETDYWPCPPSLAVVETEWRKRKASRRGAEEEEEE
EDDDSGEEMKALRERQREELSKVTSNLGKMILKEEMEKSLPIRRKTRSLPDRTPFHTSLHQGT
SKSSSLPAYGRTTLSRLPSTGFSPSGSETGSPGLQIYPYEMLVVTNKGRTKLPPGVDRMRLER
HLSAEDFSRVFAMSPEEFGKLALWKRNELKKKAELF
DISH(Dematin’s IDR with a N-terminal dual strep tag (cleavable via TEV site) and a C-terminal
His6-tag (cleavable via Sortase: LPSTG motif))
MWSHPQFEKGSGGASWSHPQFEKGGGENLYFQSERLQKQPLTSPGSVSPSRDSSVPGSPS
SIVAKMDNQVLGYKDLAAIPKDKAILDIERPDLMIYEPHFTYSLLEHVELPRSRERSLSPKAAAGG
GAGKVWADSRSPGIISQASAPRTTGTPRTSLPHFHHPETSRPDSNIYKKPPIYKQRESVGGSP
QTKHLIEDLIIESSKFPAAQPPDPNQPAKIETDYWPCPPSLAVVETEWRKRKASRRGAEEEEEE
EDDDSGEEMKALRERQREELSKVTSNLGKMILKEEMEKSLPIRRKTRSLPDRTPFHTSLHQGT
SKSSSLPAYGRTTLSRLPSTGHHHHHH
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1.3 Enzyme contructs’ amino acid sequences:
SrtA7M (Hepta-Mutant Staphylococcus aureus Sortase A)
MQAKPQIPKDKSKVAGYIEIPDADIKEPVYPGPATREQLNRGVSFAKENQSLDDQNISIAGHTFI
DRPNYQFTNLKAAKKGSMVYFKVGNETRKYKMTSIRNVKPTAVEVLDEQKGKDKQLTLITCDD
YNEETGVWETRKIFVATEVKLEHHHHHH

TEV (TEV protease)
GHIVWPDYANILKEVFGGARMACVTSAHMAGANGSILKKAEETSRATMHKPVIFGEDYVTEADL
PYTPLHLEVNAEMERMYYLGRRALTHGKRRKVSVNNKRNRRRKVAKTYVGRDSIVEKIVVPHT
ERKVDTTTAVKDTCNEVSTQLVHNSMPKRKKQKNFLPATSLSNVYAQTWSIVRKRHMQVEIISK
KSVRAKVKRFEGSVQLFASVRHMYGERKRVDLRIDNWQQKTLLDLAKRFKNERVDQSKLTFG
SSGLVLRQGSYAPAHWYRHGMFIVRGRSDGMLVDARAKVTFAVCYSMTHYHHHHHH

Section 2: Methods New to the Smirnov lab
New to the lab: All non-isotopically enriched villin 4 constructs were grown to an OD 600nm of 0.60.8. While all non-isotopically enriched dematin constructs were grown to an OD of 0.8-0.9 prior
to induction with IPTG. (see materials and methods section 2.5 protein expression *)
New to the lab: 15N incorporation of dematin utilized 1 L of salt wash and 1 L M9 instead of the
500 mL of salt wash and M9 used for V4 constructs. (see materials and methods section 2.5
protein expression **)

New to the lab: Dematin expressed within inclusion bodies is solubilized via urea. (see materials
and methods section 2.6 lysate preparation)

New to the lab: Denatured IMAC and denatured to native IMAC purifications for His6 tagged
dematin. (see materials and methods section 2.7.1 Immobilized metal affinity chromatography)

New to the lab: Purification of strep-tagged proteins is effective in both native and denatured
states (up to 6M urea). (see materials and methods section 2.7.3 Strep purifications)
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